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ABSTRACT

Environmental mastitis is of increasing prevalence in well managed dairy
herds throughout the world. Of the environmental pathogens, Streptococcus
uberis is one of the most prevalent, accounting for a significant proportion of
clinical and subclinical intramammary infections in lactating and nonlactating
dairy cows and heifers. In spite of this, the pathogenesis of S. uberis mastitis is
not well understood. The objective of this study was to determine dynamics of
leukocytes and cytokines during experimentally-induced S. uberis mastitis. Five
Jersey and 5 Holstein cows were challenged via intramammary inoculation with
S. uberis into 2 uninfected mammary glands. One uninfected unchallenged
mammary gland from each cow served as a negative control. Rectal
temperatures, blood and milk samples were collected frequently for one week
after challenge. Clinical status of mammary glands was recorded twice daily
during milking. Milk samples were collected to enumerate bacteria and somatic
cells, and to determine concentrations of tumor necrosis factor-α (TNF-α),
interleukin-1β (IL-1β) and interleukin-8 (IL-8). Neutrophils were isolated from
blood to determine expression of CD11b, CD18 and CD62 during the course of
experimental infection. Sixteen of 20 challenged mammary glands developed
clinical mastitis between 84 and 108 hours after intramammary challenge, and
peak clinical signs of mastitis were observed at 144 hours. The number of S.
uberis in milk from challenged mammary glands increased significantly (P<0.05)
v

by 48 hours after challenge, in spite of a massive leukocyte infiltration from the
bloodstream, evidenced by an increase in the number of somatic cells in milk
which began at 18 hours after challenge (P<0.001) and remained elevated
throughout the study period. Significant amounts of TNF-α, IL-1β and IL-8 in milk
were detected 66 hours after challenge (P<0.05). Peak concentrations of TNF-α
were observed at 120 hours after challenge, preceding peak clinical signs.
Concentrations of IL-1β in mammary secretions fluctuated considerably from 66
to 144 hours after challenge, but were significantly higher (P<0.01) than
prechallenge values and values found in milk from control mammary glands.
Similar to TNF-α, peak IL-8 concentrations were observed at 120 hours after
challenge. The 4 challenged mammary glands that did not become infected
exhibited an increase in somatic cells and IL-1β concentrations in a pattern that
appeared to be similar to that of challenged infected mammary glands, but of
lesser magnitude. Expression of CD11b was upregulated at 84, 90 and 114
hours after challenge (P<0.05), and expression of CD18 was increased 20% at
48 hours after challenge (P<0.05). Expression of CD18 decreased sharply 96
hours after challenge and remained depressed until the end of the sampling
period (P<0.01). Results from this experiment demonstrated that S. uberis
experimental intramammary infection induced local production of TNF-α, IL-1β
and IL-8, which may play a role in the pathogenesis of S. uberis mastitis.
Furthermore, an increase in somatic cells in milk occurred earlier than increases
in adhesion molecule expression or cytokine production, suggesting that other

vi

mediators may be involved in initial leukocyte recruitment into the mammary
gland after infection.
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Chapter 1
INTRODUCTION

Bovine mastitis is the most common and expensive disease affecting dairy
cows throughout the world. This disease is typically caused by bacteria and
characterized by inflammation of the mammary gland and abnormal appearance
of lacteal secretions regardless of the etiologic agent. As a result of mastitis, both
milk yield and milk quality are affected greatly. Reduced milk yield and alterations
in milk composition due to mastitis are influenced by the severity of the
inflammatory response, which in turn is influenced by the mastitis pathogen
causing the infection (Oliver and Calvinho, 1995). The National Mastitis Council
estimated that mastitis costs dairy producers in the U.S. $2 billion annually
(National Mastitis Council, 1996). Therefore, mastitis continues to be the most
significant limiting factor to profitable dairy production worldwide.
Signs of mastitis vary according to severity and duration of infection.
Intramammary infection (IMI) may result in clinical or subclinical disease.
Mammary glands with subclinical mastitis show no obvious signs of disease. Milk
from cows with subclinical mastitis appears normal; however, microorganisms
and inflammatory cells are present in high numbers. In many herds, subclinical
mastitis is by far the most prevalent and causes the greatest overall loss due to
lowered milk production (National Mastitis Council, 1996). Clinical mastitis, on the
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other hand, is characterized by abnormal milk, such as clots and clumps, and/or
visible alterations of the udder, such as redness and swelling. In severe cases,
there may be systemic signs such as elevated temperature, anorexia and
septicemia, which may cause death of the animal (Leigh, 1999).
Over 135 infectious agents have been associated with clinical mastitis
(Watts, 1988). Mastitis causing organisms have been categorized as contagious
or environmental pathogens based on their distinct characteristics of distribution
and interaction with the teat and teat duct (Calvinho et al., 1998). Contagious
pathogens live and multiply in the cow’s mammary gland and are spread from
animal to animal primarily during milking. Environmental pathogens are those
whose primary reservoir is the environment where cows live and not infected
mammary glands (Smith and Hogan, 1993). Contagious pathogens include
Staphylococcus aureus, Streptococcus agalactiae, Mycoplasma species and
Corynebacterium bovis, while environmental pathogens include a heterogeneous
group of bacterial genera, species and strains (Calvinho et al., 1998). The most
frequently isolated environmental pathogens are streptococci other than S.
agalactiae (environmental streptococci) and Gram-negative bacteria (Smith et al.,
1985; Oliver, 1988; Smith and Hogan, 1993).
Control of bovine mastitis is very difficult due to the diversity of pathogens
capable of causing the disease. Mastitis is present in every herd; however, rates
of infection and types of bacteria causing mastitis vary tremendously between
herds (Oliver and Mitchell, 1984). Current mastitis control programs developed in
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the late 1960’s are aimed at reducing the prevalence of mastitis by reducing the
incidence, duration and likelihood of transmission of an infection. Therefore, the
greatest control has been achieved against those pathogens transmitted from
cow to cow. These control programs are based on hygiene including pre- and
postmilking teat disinfection, therapeutic and prophylactic antibiotic therapy and
culling of chronically infected cows. Acceptance and application of these
measures has led to considerable progress in controlling contagious mastitis
pathogens. However, these measures have been less effective against
environmental pathogens (Smith et al., 1985). Consequently, environmental
mastitis has become a major problem, particularly in well-managed dairy herds
that have successfully controlled contagious pathogens (Oliver and Mitchell,
1984; Oliver, 1988; Bennet, 1990; Todhunter et al., 1995). It has been
hypothesized that the niche vacated by contagious mastitis pathogens becomes
occupied by environmental mastitis pathogens, resulting in an increased
prevalence of environmental pathogen IMI (Jayarao et al., 1999). Among the
environmental streptococci, Streptococcus uberis is the most prevalent,
accounting for a significant proportion of subclinical and clinical IMI in both
lactating and nonlactating cows (Smith et al., 1985; Oliver, 1988; Todhunter et
al., 1995; Jayarao et al., 1999; Phuektes et al., 2001).
Therapeutic and prophylactic antibiotic therapy for the control of mastitis
presents three major concerns. Firstly, bacteriologic cure rates for therapy during
lactation are not as high as in vitro sensitivity data would indicate (Keefe and
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Leslie, 1997). Secondly, the presence of antibiotic residues in milk for human
consumption is a major concern in today’s dairy industry, and mastitis is the
number one cause of antibiotic use in dairy cows (Moore and Heider, 1984).
Thirdly, there is concern that widespread use of antibiotics for treatment and
prevention of mastitis will increase the risk of antibiotic resistance of pathogens
that can cause disease in humans. The desire to protect hypersensitive
individuals from exposure to specific antibiotics and to reduce the remote
possibility of the emergence of antibiotic resistant organisms in milk or in human
enteric flora has led to strict and extensive surveillance programs for detection of
antibiotic residues in milk (Allison, 1985). Although the risk to human health from
antibiotic residues in milk is negligible, sectors of society object to being
involuntarily exposed to drug residues. Limiting the use of antibiotics to treat
mastitis would greatly benefit dairy farmers, since discarded milk during antibiotic
treatment together with decreased milk production account for the largest
economic losses associated with mastitis (National Mastitis Council, 1996).
Based on limitations of current methods of mastitis control and concerns
regarding use of antibiotics in food producing animals, it seems appropriate to
consider alternative non-antibiotic methods for the prevention and control of
environmental mastitis. In addition to the required practices of good herd
management and hygiene, alternative control measures should include
manipulation of host defense mechanisms. This approach requires knowledge of
host and pathogen factors involved in the development and establishment of IMI
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as well as defense mechanisms within the udder and ways to enhance these
mechanisms (Calvinho et al., 1998). However, the pathogenesis of S. uberis
mastitis is incompletely understood. More insight into mechanisms of IMI by S.
uberis will ultimately lead to more successful control and prevention of S. uberis
mastitis in dairy cows.
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Chapter 2
LITERATURE REVIEW

CHARACTERISTICS OF STREPTOCOCCUS UBERIS

Epidemiology
Streptococcus uberis is ubiquitous in the cow’s environment (Smith et al.,
1985). It has been isolated from many sites of the cow including tonsils, genital
tract, rumen, rectum and skin (Kruze and Bramley, 1982). However, this
organism does not contribute significantly to disease outside the mammary
gland. It would appear that S. uberis has evolved to become a successful and
specialized pathogen of the bovine mammary gland (Leigh, 1997). The organism
can also be isolated in high numbers from bedding material used for cattle
(Bramley, 1982), which is thought to act as an important vector that can
contaminate teats. Furthermore, S. uberis has been isolated from heavily used
pasture in numbers similar to those seen in bedding materials (Harmon et al.,
1992).
Intramammary infection with S. uberis is common throughout the world. A
review by Hogan and Smith (1997) cited four surveys conducted in the previous
10 years in Canada, Ohio, the Netherlands and the United Kingdom, which
indicated that S. uberis was responsible for 14 to 26% of all clinical mastitis
6

cases. Interestingly, S. uberis is also a significant cause of bovine mastitis in
New Zealand, Australia and Argentina, where the dairy industry is primarily
pasture based (Williamson et al., 1995; Pankey et al., 1996; Acuña et al., 2001;
Phuektes et al., 2001).

Biochemical and serological characteristics
Streptococcus uberis is identified routinely on the basis of colony
morphology and esculin hydrolysis; however, subsequent culture confirmation
requires additional tests. One of the most widely used systems for the
identification of streptococci is the API 20 Strep System (bioMerieux, Vitek Inc.),
which consists of 20 miniaturized biochemical tests in a plastic strip. In a study by
Jayarao et al. (1991b), this system identified 57 of 60 S. uberis isolates correctly.
In the same study, the Vitek Gram-positive identification system (GPI, Vitek
Systems), using 15 miniaturized biochemical tests, also correctly identified 57 of
60 isolates.
Streptococcus uberis is serologically heterogeneous. Jayarao et al.
(1991b) used a streptococcal agglutination system containing Lancefield group
A-, B-, C-, D-, F- and G-specific antibodies to determine serogroups of 60 S.
uberis isolates. Although 16 isolates were classified as belonging to serogroup G,
the remaining isolates did not belong to any of the serogroups tested.
Consequently, serological tests appear to be of little value for identification of S.
uberis (Leigh, 1999).
7

Molecular biology techniques
Using chromosomal DNA hybridization, Garvie and Bramley (1979)
demonstrated the presence of two S. uberis genotypes (types I and II). Williams
and Collins (1990) determined the nucleotide sequences for 16S ribosomal RNA
of S. uberis genotypes I and II and showed that the two genotypes were
phyolgenetically distinct and proposed that S. uberis genotype II be designated
Streptococcus parauberis. However, cultural, morphological, biochemical and
serological

characteristics

of

the

two

closely

related

species

are

indistinguishable. Techniques developed by Jayarao et al. (1991a; 1992b) based
on restriction fragment length polymorphism (RFLP) of polymerase chain
reaction (PCR) amplified 16S rRNA genes, indicated that the predominant
organism isolated from infected mammary glands was S. uberis and that S.
parauberis occurred infrequently (Oliver et al., 1998).
A number of techniques have been investigated for differentiation and
subtyping of individual S. uberis strains. Restriction endonuclease fingerprinting
of chromosomal DNA (Jayarao et al., 1991c), rRNA gene (rDNA) restriction
patterns (Williams and Collins, 1991; Jayarao et al., 1992b) and DNA
amplification fingerprinting (Jayarao et al., 1992a) have been shown to be useful
procedures for typing S. uberis. Each procedure has confirmed the wide variety
of strains which are able to infect the mammary gland and substantiates the view
that S. uberis IMI do not result from contagious transmission of a limited number
of virulent strains within a herd (Leigh, 1999).
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Virulence factors
For IMI to occur, mechanisms associated with avoidance of phagocytic
defenses, adherence to epithelial cells and colonization of mammary gland tissue
are probably present (Oliver et al., 1998). By various mechanisms, S. uberis is
capable of finding beneficial conditions for growth and avoidance of mammary
gland defense systems. Potential virulence factors and pathogenic mechanisms
for S. uberis are presented in Table 1.

1- Capsule
Avoidance of phagocytosis is probably one of the more important mechanisms
that bacterial pathogens possess to establish an IMI. Bacterial capsules exert
their antiphagocytic functions through mechanisms such as electrostatic
repulsion, antigenic mimicry and low immunogenicity, antigen masking, physical
barrier between bacteria and phagocyte, binding and depletion of opsonic factors
and suppression of phagocyte cell activity (Speert et al., 1983; Almeida et al.,
1992). Matthews et al. (1994b) reported that about 50% of S. uberis isolates
were encapsulated. Almeida and Oliver (1993b) characterized two forms of
capsular material from S. uberis composed primarily of hyaluronic acid; a higher
molecular weight form associated with the bacterial cell and a lower molecular
weight form that apparently was released to the surrounding environment.
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Table 1. Potential virulence factors of Streptococcus uberis. 1
Virulence factor

Reference

Cell associated factors/activity
Adherence

(Almeida et al., 1996; Almeida et al., 1999a; Almeida
et al., 1999b)

Lactoferrin-binding protein

(Fang and Oliver, 1999)

Collagen-binding protein

(Gilbert et al., 1997)

Fibronectin-binding

(Almeida et al., 1996)

Hyaluronic acid capsule

(Almeida and Oliver, 1993a; Almeida and Oliver,
1993b; Matthews et al., 1994b)

Invasion

(Matthews et al., 1994a)

Laminin-binding

(Almeida et al., 1996)

M-like protein

(Almeida et al., 1996)

PMN toxin

(Leigh, 1994a)

R-like protein

(Groschup and Timoney, 1993)

Plasminogen activator

(Leigh, 1994b)

Extracellular factors
Hyaluronic acid capsule

(Almeida and Oliver, 1993b)

Hyaluronidase

(Schaufuss et al., 1989)

Uberis factor

(Skalka et al., 1980)

1

adapted from Oliver et al., 1998.
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Conflicting reports exist on the role of the capsule in resistance of S.
uberis to phagocytosis, especially by bovine macrophages. In a study by Grant
and Finch (1996), two strains of S. uberis that differed in their ability to produce
capsule and to resist phagocytosis and killing by neutrophils were both shown to
be phagocytosed and killed equally by bovine macrophages. However, Almeida
and Oliver (1993a; 1995) reported that phagocytosis and intracellular killing by
bovine mammary macrophages was significantly higher for nonencapsulated
strains than for encapsulated strains of S. uberis. Furthermore, when
encapsulated

bacteria

were

opsonized

by anticapsular antibodies,

the

antiphagocytic effect was inhibited (Almeida and Oliver, 1993a). Purified,
protease-treated capsular material diminished macrophage phagocytic and killing
activity, and this suppressive effect not only protected encapsulated strains but
also protected nonencapsulated strains of S. uberis from macrophage
phagocytosis (Almeida and Oliver, 1993a).
One of the general mechanisms that has been proposed to explain the
role of capsular components in resistance of bacteria to phagocytosis is that the
capsule may prevent binding of opsonic factors such as antibody or complement
to the bacterial cell (Horrowitz and Silverstein, 1980). A capsular and noncapsular phenotype of the same strain of S. uberis were shown to bind equal
quantities of antibody (Leigh and Field, 1994). In each case, the antibody was
intact, bound in the correct orientation and presented the Fc terminus for
interaction with receptors on phagocytic cells (Leigh and Field, 1994). Leigh and
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Field (1994) suggested that resistance of S. uberis to bactericidal action of
bovine neutrophils was not related to bound immunoglobulins. In this study,
however, bovine mammary macrophages were not evaluated, and there was no
indication of whether antiserum reacted against capsular material of S. uberis.

2- Plasminogen activator
Streptococcus uberis is highly auxotrophic and depends on acquisition of
several amino acids, vitamins, trace elements and a carbohydrate source to grow
successfully (Leigh, 1994b). Since milk from lactating mammary glands is
deficient in free or peptide associated amino acids, S. uberis must possess a
mechanism to acquire amino acids for growth. Leigh (1993) demonstrated that S.
uberis was capable of converting plasminogen to plasmin, which in turn
degraded casein and generated by-products needed for optimal bacterial growth.
A plasminogen activator, designated PauA, was isolated from S. uberis (Leigh,
1994b). However, the relationship between activation of plasminogen and
virulence is not clear since a low pathogenic strain which showed caseinolytic
activity (Leigh et al., 1990) was susceptible to killing by bovine neutrophils after
growth in medium supplemented with casein (Leigh and Field, 1991).
Results from a vaccination study using PauA suggest that this molecule
conferred partial protection against experimentally induced S. uberis mastitis in
dairy cows (Leigh et al., 1999). Three of four animals vaccinated with PauA
showed no signs of clinical mastitis, and bacterial shedding in milk was low (<103
12

colony forming units/ml of milk) in 5 of the 6 challenged quarters (Leigh et al.,
1999). The 5 quarters that resisted clinical infection showed the highest antibody
titre to PauA. Furthermore, protection was not associated with influx of large
numbers of neutrophils into the mammary gland, evidenced by somatic cell
counts for challenged quarters from vaccinated animals that never exceeded 2 x
105 cells/ml of milk (Leigh et al., 1999). These results indicate that although
establishment of infection could not be avoided, challenged quarters of
vaccinated cows did not develop clinical mastitis, probably by reduction in the
rate of colonization of the gland.

3- Lactoferrin-binding proteins
Streptococcus uberis expresses at least two surface proteins, designated
lactoferrin-binding proteins, that bind to lactoferrin (Lf) in milk (Fang and Oliver,
1999). Lactoferrin is an iron-binding protein present in bovine milk which
increases dramatically in concentration during involution and during infection of
the bovine mammary gland (Smith and Oliver, 1981). Additionally, bovine Lf has
been found to bind to several types of host cells, including bovine mammary
epithelial cells (Rejman et al., 1994). Because S. uberis bound to Lf in milk and
to purified Lf, it was hypothesized that Lf acted as a bridging molecule between
bacteria and mammary epithelial cells or phagocytic cells in the pathogenesis of
S. uberis mastitis (Fang and Oliver, 1999). More recently, Fang et al. (2000)
demonstrated that presence of Lf in the culture medium and in milk enhanced
13

adherence of S. uberis to mammary epithelial cells, providing further evidence to
substantiate this hypothesis. Lactoferrin-binding proteins have also been
detected in S. dysgalactiae subspecies dysgalactiae and S. agalactiae isolated
from cows with mastitis (Park et al., 2002).

4- Adherence of S. uberis to mammary epithelium and to extracellular
matrix proteins
A common concept in the pathogenesis of infectious diseases is that
microorganisms that infect mucosal surfaces should adhere to these surfaces to
allow multiplication and colonization of that specific mucosa. Adherence should
be strong enough to resist the flushing effect of normal secretions, and
sufficiently specific to provide the microorganism with sources of nutrients that
support colonization and spreading of the infection (Oliver et al., 1998).
Hasty et al. (1992) proposed a multi-step model for adherence of
Streptococcus species to epithelial cells which involved two distinct kinetic steps
with different affinity interactions between host receptors and bacterial adhesins.
In the first step, adherence was weak and of low specificity and involved
electrostatic/hydrophobic interactions. Lipoteichoic acid (LTA) was proposed as
the model adhesin of this step. The second step involved a strong adhesin-host
receptor interaction, was non-hydrophobic, and involved highly specific bacterial
cell ligand-host cell receptor interactions. It also provided stability to the
attachment between bacteria and host cells. M protein and other ligands such as
14

fibronectin-binding protein and vitronectin-binding protein were proposed as the
main adhesins involved in this step (Hasty et al., 1992).
Almeida et al. (1996) showed that M protein and LTA contributed to
adherence of S. uberis to mammary epthelial cells and suggested participation of
the eukaryotic cell cytoskeleton and interaction between epithelial cell
membranes and S. uberis. In addition, Almeida et al. (1996) indicated that S.
uberis bound to extracellular matrix proteins (ECMP). A nonencapsulated strain
of S. uberis adhered significantly better to mammary epithelial cells, but an
encapsulated strain adhered better to laminin, collagen and fibronectin. Of the
three ECMP tested in the study by Almeida et al.(1996), both strains showed
greater binding to laminin. This agrees with Fillipsen et al. (1990) who showed
adherence of S. uberis to ECMP and with Thomas et al. (1992) who indicated
that adherence of S. uberis occurred where the endothelium was coated with
fibrin. Gilbert et al. (1997) suggested that laminin, collagen and bovine mammary
epithelial cells exert a positive regulation on S. uberis which leads to increased
synthesis of specific proteins, and that these proteins are probably expressed in
vivo during infection. Additionally, incubation of S. uberis with ECMP resulted in
increased adherence to bovine mammary epithelial cells (Almeida et al., 1999b).
Therefore, it is likely that ECMP exert a positive regulation and expression of
virulence factors in S. uberis that enhances colonization of mammary epithelial
cells (Almeida et al., 1999b).
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5- Streptococcus uberis invasion of mammary epithelial cells
Matthews et al. (1994a) demonstrated that S. uberis invaded bovine
mammary epithelial cells based on ultrastructural changes in the mammary
epithelial cells’ cytoplasmic membrane when S. uberis was in close proximity or
made contact. Endocytic-like invaginations and development of pseudopod-like
elongations that extended around and engulfed bacteria were evident where S.
uberis interacted with epithelial cells. Internalized bacteria were observed
enclosed in membrane-bound vacuoles (Matthews et al., 1994a). The invasion
process involved mammary cell cytoskeleton elements, specifically F-actin.
However, no morphological changes indicative of cell damage were observed
following bacterial invasion (Matthews et al., 1994a). Data from experimental
infection of bovine mammary glands showed S. uberis penetrating secretory
epithelium 18 to 24 hours after infection (Thomas et al., 1994), further supporting
the findings of in vitro studies.
Invasion of mammary epithelial cells by S. uberis seems to require de
novo synthesis of several bacterial proteins (Matthews et al., 1994c).
Streptococcus uberis synthesized several new bacterial proteins when cocultured
with bovine mammary epithelial cells (Matthews et al., 1994c; Fang et al.,
1998b). When bacterial protein synthesis was inhibited in coculture with
mammary epithelial cells, the ability of S. uberis to invade mammary epithelial
cells decreased (Matthews et al., 1994c). The ability of S. uberis in vivo to invade
bovine mammary epithelial cells could result in chronic infections, since
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internalized bacteria are protected from host defense mechanisms and from the
action of most antimicrobials (Oliver et al., 1998).

THE INFLAMMATORY RESPONSE IN THE MAMMARY GLAND

Mammary gland immunity
Defense of the mammary gland against mastitis-causing pathogens is
mediated by several anatomical, cellular and soluble protective factors (Sordillo
et al., 1997). Once bacteria successfully penetrate the teat orifice, the efficiency
of these mechanisms determines the resistance or susceptibility of the mammary
gland to the establishment of new IMI.

1- Anatomical defenses
Almost invariably, mastitis occurs when bacteria gain entrance into the
mammary gland through the teat canal. The teat canal is typically sealed
between milkings by a keratin plug derived from epithelial cells lining the canal.
Some components of the keratin plug have known microbicidal activity (Treece et
al., 1966), but the major role of this plug is to serve as a physical barrier
preventing microbial access to the teat sinus (Capuco et al., 1992).
The teat end contains involuntary sphincter muscles that maintain tight
closure between milkings and prevent bacteria from penetrating into the gland
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(Hamann and Burvenich, 1994). The importance of the teat canal in prevention of
IMI was documented as early as 1953 (Murphy and Stuart, 1953). Under the best
of machine milking conditions, the process of milk accumulation and withdrawal
from the gland leaves the involuntary teat sphincter muscle in a flaccid state that
requires up to 2 hours for muscular tone to return (Schultze and Bright, 1983).
Once this musculature contracts to close the teat end, it forms an effective seal
of the streak canal and enables reformation of the keratin plug. Increased
patency of the teat sphincter muscles is directly related to incidence of mastitis
(Murphy and Stuart, 1953). Additionally, teat end lesions can be induced by a
variety of traumatic insults, such as improper milking machine performance,
chemical damage from teat dips and exposure to cold temperatures and wind
(Francis, 1981; Sieber and Farnsworth, 1981; Shearn and Hillerton, 1996). These
teat end lesions may represent the primary insult to the teat skin as a prelude to
IMI.

2- Soluble defenses
Many soluble factors present in milk act in collaboration with innate and
immune defense mechanisms. They include immunogloblulins (Ig), complement
fractions, Lf, lysozyme and lactoperoxidase. Immunoglobulins are produced by
local plasma cells or selectively transported from serum (Sordillo and Nickerson,
1988b). The concentration of Ig in mammary secretions is dependent upon the
stage of lactation, the degree of permeability of secretory tissue and the number
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of Ig-producing cells present. In healthy mammary glands, the concentration of Ig
is low during lactation but increases during the nonlactating period to reach peak
concentration during colostrogenesis (Sordillo and Nickerson, 1988b). Although
IgG1 is the predominant isotype in mammary secretions of healthy cows,
neutrophils can transport IgG2 to the mammary gland as they emigrate towards
the site of inflammation (Musoke et al., 1994). Immunoglobulins, together with
complement fraction C3b, act as important opsonins that facilitate phagocytosis
of bacteria by neutrophils during inflammation (Reiter, 1978; Howard et al., 1980;
Targowski, 1983).
Lactoferrin, an iron-binding glycoprotein produced by epithelial cells and
neutrophils, is bacteriostatic by its ability to prevent growth of bacteria that have
an iron requirement (Smith and Oliver, 1981). However, streptococci are resistant
to the antibacterial effects of lactoferrin (Smith and Oliver, 1981; Todhunter et al.,
1985) probably because streptococci do not have a high requirement for iron
(Weinberg, 1978). Fang and Oliver (1999) showed that different strains of S.
uberis bound to Lf through specific lactoferrin-binding proteins. Streptococcus
uberis may utilize Lf as a bridging molecule to adhere and later invade mammary
epithelial cells (Fang and Oliver, 1999).
Lysozyme is a bactericidal protein that cleaves peptidoglycans from the
cell wall of Gram-positive bacteria as well as the outer membrane of Gramnegative bacteria (Reiter, 1978). However, because bovine milk contains very
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low concentrations of lysozyme (Vakil et al., 1969), the real protective role of this
enzyme in bovine mastitis is unknown.
Lactoperoxidase, in the presence of thiocyanate and hydrogen peroxide,
is bacteriostatic for gram-positive bacteria such as S. aureus and streptococci
and bactericidal for gram-negative bacteria (Outteridge and Lee, 1988).
Lactoperoxidase is present in high concentrations in bovine milk (Reiter, 1978;
Reiter and Harnulv, 1984). However, it is generally assumed that milk does not
contain hydrogen peroxide (Reiter and Harnulv, 1984), and thyocianate
concentrations may vary greatly depending on external factors such as nutrition
(Wood, 1975); therefore, the importance of this system against mastitis causing
pathogens is questionable.

3- Cellular defenses
Once bacteria penetrate the teat orifice, they are exposed to mammary
gland defense mechanisms that will attempt to eliminate or control bacterial
invasion before any serious damage is done to mammary tissue. Resident and
newly recruited leukocytes play a key role during the initial stages of
pathogenesis.
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a- Macrophages
Macrophages are the predominant cell type found in milk from healthy
mammary glands (Lee et al., 1980; McDonald and Anderson, 1981; Sordillo and
Nickerson, 1988a), and are considered the first line of defense against invading
pathogens. Macrophages have the ability of ingesting bacteria, cellular debris
and accumulated milk components (Sordillo and Nickerson, 1988a). However,
because of indiscriminate ingestion of fat and casein, macrophages suffer
degranulation and loss of pseudopodia resulting in dramatically reduced
bactericidal ability (Paape and Guidry, 1977; Reinitz et al., 1982). While
somewhat helpless against invading bacteria, macrophages have the ability to
release a powerful array of cytokines which play a key role in the subsequent
inflammatory response to eliminate infection (Craven, 1983).
An effective response requires that macrophages recognize pathogenassociated molecular patterns that distinguish infectious agents from self, and in
addition, discriminate among pathogens (Janeway, 1992). Two members of the
Toll-like receptor (TLR) family play a key role in this process. TLR4 recognizes
LPS, whereas TLR2 recognizes various fungal, gram-positive and mycobacterial
components (Hoshino et al., 1999; Lien et al., 1999; Flo et al., 2000; Ozinsky et
al., 2000). This family of receptors has the capacity to recognize a wide spectrum
of stimuli, providing some “specificity” to the innate immune response. At least
eight TLR have been identified (Means et al., 2000). The intracellular domains of
TLR are similar to the intracellular domain of the interleukin-1 (IL-1) receptor, and

21

these regions are referred to as Toll/IL-1R domain. Activation of TLR triggers a
multi-step signaling pathway which results in activation of particular target genes,
mostly through activation of nuclear factor κB (NFκB) (O'Neil and Greene, 1998).
This signal transduction pathway is highly similar to the one activated by IL-1
(O'Neil and Greene, 1998). Although likely present, no reports exist on the
presence of TLR on bovine mammary gland macrophages.
Additionally, mammary gland macrophages are important antigen
processing and presenting cells (Politis et al., 1992). Bacterial antigens are
processed within macrophages and presented on the cell surface together with
major histocompatibility complex (MHC) class II molecules. This alignment allows
specific lymphocytes to recognize a particular antigen and mount a specific
immune response towards it. However, Politis et al. (1992) showed that
mammary gland macrophages are less efficient than blood monocytes in
cytokine production, antigen presentation and antigen-specific T-cell proliferation.
Furthermore, Politis et al. (1992) demonstrated that this inferior ability was not
due to suppressive activity of these cells but to an overall decreased
functionality. In contrast, Sordillo et al. (1995) reported that mammary gland
macrophages have an enhanced ability to produce tumor necrosis factor-α (TNFα) when compared to blood monocytes during the periparturient period, so it is
not that mammary gland macrophages are hyporesponsive altogether. It seems
evident that mammary gland macrophages show functional differences
compared with blood monocytes. Furthermore, studies by Politis et al. (1992) and
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Sordillo et al. (1995) were conducted with two different stimulatory agents for
macrophages. It could be possible that macrophages elicit distinct responses to
different etiological agents of mastitis.

b- Neutrophils
Polymorphonuclear leukocytes (PMN) or neutrophils generally constitute
less than 20% of the cells present in milk from healthy mammary glands (Lee et
al., 1980; McDonald and Anderson, 1981). However, in milk from infected
mammary glands, neutrophils constitute >90% of total leukocytes (Paape et al.,
1981; Sordillo et al., 1987; van Werven et al., 1999). Neutrophils travel from the
bloodstream to the site of infection by a tightly regulated migration mechanism.
Influx of PMN into the mammary gland occurs at a low level for immune
surveillance but increases rapidly in response to bacterial infection, where potent
inflammatory mediators guide PMN towards the site of infection (Paape et al.,
2000). Neutrophils play a key role in defense of the mammary gland; in fact, it
has been been shown that the severity and duration of mastitis is related critically
to the promptness of leukocyte migration and the bactericidal activity of
leukocytes at the site of infection (Hill, 1981; Kehrli et al., 1989). However, similar
to macrophages, milk PMN are less phagocytic than blood PMN (Jain and
Lasmanis, 1978). This has been attributed to ingestion of milk components such
as fat and casein by the PMN (Russel et al., 1976; Paape and Guidry, 1977), and
more recently, to a direct effect of diapedesis across mammary epithelium, which
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reduced phagocytosis and oxidative burst of bovine neutrophils (Smits et al.,
1999). These factors may explain why such high numbers of PMN are required to
prevent infection in the bovine mammary gland (Craven and Williams, 1984).
Bovine neutrophils differ somewhat from neutrophils of other species. Like
other species, they contain azurophilic and specific granules. The most important
antibacterial

mechanism

derived

from

azurophilic

granules

is

the

myeloperoxidase-hydrogen peroxide-halide system, one of the most potent
bactericidal mechanisms of neutrophils (Roth, 1994). A membrane-associated
oxidase enzyme complex converts oxygen to superoxide anion, which then
undergoes further reactions to form hydrogen peroxide, hydroxyl radical and
singlet oxygen (Densell and Mandell, 1990). Myeloperoxidase catalyzes a
reaction between hydrogen peroxide and halide ions (iodide, bromide, and
chloride), resulting in halogenation and oxidation of bacterial surface components
and generation of hypochlorous acid, aldehydes and chloramines (Roth, 1994).
Additionally, bovine neutrophils contain a third type of granules, larger and more
numerous than the other two classes, which contain a variety of oxygenindependent bactericidal compounds (Gennaro et al., 1983).
Another difference of bovine neutrophils is that they lack Fc receptors for
IgG1 (Howard et al., 1980). Consequently, IgG1 cannot function as an opsonin for
bovine neutrophils. PMNs have membrane receptors for the Fc component of
IgM and IgG2 and for complement fraction C3b, which are necessary for
mediating phagocytosis of invading bacteria.
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Unlike

most

mammalian

species,

bovine

neutrophils

are

not

chemotactically attracted to N-formylated bacterial peptides (Craven, 1986),
which are fairly unique to prokaryotic organisms. Reasons for this are unknown,
but might be related to the important function that microbial flora play in ruminant
digestion, and the fact that it would not be beneficial for animals to develop an
immune response towards beneficial microbes involved in digestion (Kehrli and
Harp, 2001). It is not known how ruminants efficiently recognize the presence of
bacterial peptides in undesirable locations; possibly, N-formylated bacterial
peptides are recognized by the ruminant immune system in a more modest
manner that results in an indirect initiation of an inflammatory response (Kehrli
and Harp, 2001).

Inflammation of the mammary gland
Native defenses of the bovine mammary gland are challenged
continuously by environmental exposure to bacteria. Once a pathogen has
penetrated the teat orifice, innate and adaptive immune systems will attempt to
prevent infection before serious damage is caused to secretory tissue. The
sequence of events that take place is characterized initially by an acute
inflammatory reaction dominated by neutrophil recruitment into mammary
secretion. This is evidenced initially by an increase in somatic cell count and
appearance of abnormal milk (flakes, clots, clumps).

25

Initial signals that trigger acute inflammation in the mammary gland are
varied and redundant. Many chemical mediators are released within hours of
infection and include chemotactic complement fractions, prostaglandins, platelet
activating factor, thromboxane A2 and acute phase cytokines such as IL-1, TNFα, and interleukin-8 (IL-8) (Giri et al., 1984; Rose et al., 1989; Shuster et al.,
1993; Shuster et al., 1997; Riollet et al., 2000). These factors are released by
leukocytes in milk or by mammary epithelial cells in response to bacterial
products, and play a key role in the battle between the cow’s defense
mechanisms and the pathogen.

1- Fundamentals of leukocyte recruitment
The first step involved in leukocyte recruitment is the initial contact and
loose interaction between leukocytes in the bloodstream and endothelial cells
from post-capillary venules. Rolling of leukocytes against the blood vessel wall is
mediated by members of the selectin family (Zimmerman, 1992). Molecules of
the selectin family are heavily glycosylated, single chain integral membrane
proteins that include CD62P, CD62E (both present in endothelial cells) and
CD62L (present in leukocytes; Table 2). Rolling of leukocytes is mediated in part
by CD62L which binds to mucin-like glycoproteins (GlyCAM-1 and CD34)
expressed on postcapillary endothelial cells (Robbins, 1994). CD62L is crucial for
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Table 2. Leukocyte-endothelial adhesion molecules. 1

ENDOTHELIAL

FAMILY

MOLECULE
E-selectin (CD62E)

LEUKOCYTE

FAMILY

DISTRIBUTION

Oligosaccharide

Neutrophils

RECEPTOR
Selectin

Sialyl-Le
glycoprotein

T-cells
Monocytes

P-selectin (CD62P)

Selectin

Sialyl-Le

Oligosaccharide

glycoprotein

ICAM-1

Immunoglobulin

LFA-1

Neutrophils
Monocytes

β2 integrin

All leukocytes

β1 integrin

Lymphocytes

Mac-1
VCAM-1

Immunoglobulin

VLA-4

Monocytes
Basophils
Eosinophils
GlyCAM-1
CD34

Mucin-like

L-selectin (CD62L)

glycoproteins

Selectin

Neutrophils
Lymphocytes
Monocytes

1

From Robbins, 1994.
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recruitment of neutrophils into inflamed tissues; it acts by slowing down
leukocytes upon contact with its specific ligands (Butcher, 1991). Additionally,
during an inflammatory response, locally produced cytokines stimulate increased
expression of CD62P and CD62E on endothelial cells, which interact with
undefined ligands on leukocytes and further facilitate margination of leukocytes
(von

Andrian

et

al.,

1993).

Neutrophils

activated

by

cytokines

or

chemoattractants shed CD62L (Kishimoto et al., 1989), which is a prerequisite
step for β2- integrin mediated tight adhesion.
Integrins are the major family of cell surface receptors that mediate
adhesive cell to cell interactions and attachment to extracellular matrix (Hynes,
1992; Sonnenberg, 1993). Structurally, integrins are heterodimeric glycoproteins
made up of alpha and beta chains. The β2-integrins are mainly involved in
leukocyte-endothelial cell contact (Table 2). The β2-integrin family consists of
distinct α chains, CD11a, CD11b and CD11c that share a common β chain
(CD18). Distribution of β2-integrins on leukocyte surfaces varies with cell type
and state of activation. The most important β2-integrin involved in neutrophil
recruitment into inflamed tissue is Mac-1 (CD11\CD18; Arnaout, 1990). It is
predominantly found on granulocytes with some expression on macrophages and
natural killer cells (Arnaout, 1990). Mac-1 is predominantly stored in cytoplasmic
granules; upon cellular activation these cytoplasmic granules translocate to the
cell surface and expression of Mac-1 increases markedly (Miller et al., 1987;
Arnaout, 1990). In addition to their critical role in adhesion, it is likely that β228

integrins mediate inside-out signaling and extracellular conformational changes
(Miller et al., 1987) with a consequent increase in integrin affinity.
The immunoglobulin family molecules interact with β2-integrins expressed
on leukocytes. Intracellular adhesion molecule 1 (ICAM-1) is an integral
membrane protein that binds to Mac-1 on leukocytes (Diamond et al., 1991).
ICAM-1 is expressed in low levels on normal endothelium; however, expression
of ICAM-1 increases markedly on cytokine- simulated endothelial cells (Dustin et
al., 1986). Increased expression is important for high affinity binding of
leukocytes to postcapillary venules and subsequent migration into inflamed
tissues (Dustin et al., 1986).
The currently accepted model for neutrophil adhesion and transmigration
in acute inflammation postulates the following steps (Robbins, 1994):
•

Initial rapid and relatively loose adhesion that accounts for rolling,
involving mainly the naturally occurring CD62L and CD62P, and, in
cytokine induced endothelium, CD62E.

•

Activation of leukocytes by agents made by endothelium or other cells
or emanating from the site of injury, to increase avidity of integrins.

•

Strong binding of leukocytes and endothelial cells, largely through β2integrin-ICAM pathway, and consequent transmigration.

Mechanisms controlling PMN transepithelial migration in the mammary gland are
likely

to

be

unique

due

to

multiple
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roles

of

lactating

mammary

epithelium. Furthermore, leukocytes must not only traverse the capillary
endothelium but also the extracellular matrix and mammary epithelial cells in
order to arrive to the alveolar lumen. Smits et al. (2000) investigated the role of
Mac-1 in diapedesis across the blood-milk barrier in an in vitro model and
reported that neutrophil migration across mammary endothelial cells was almost
completely dependent on CD18, the β chain of β2-integrins. Neutrophil
diapedesis across mammary epithelial cells was dependent to a greater extent
on CD11b (Smits et al., 2000). These results provide evidence that different
mechanisms exist for neutrophil migration across various cell layers of the bloodmilk barrier.

2- Acute phase response mediators
Upon bacterial invasion of the mammary gland, a wide array of
inflammatory mediators is released from bacterial cells as well as from host cells
that react to the foreign presence and ‘give notice’ to the immune system in order
to attempt to control and eliminate the infection. These inflammatory mediators
include a variety of bacterial products; as well as prostaglandins; leukotrienes;
histamine; complement fractions; and acute phase cytokines such as IL-1, TNFα, interleukin-6 (IL-6), interleukin-8 (IL-8) and several colony stimulating factors
(Giri et al., 1984; Rose et al., 1989; Shuster et al., 1993; Riollet et al., 2000).
These bioactive products have varied effects on local tissues and also direct
leukocyte migration into inflamed tissues. Additionally, they exert systemic effects
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such as fever, breakdown of the blood-milk barrier and increased bone marrow
output of leukocytes to replenish supplies in the bloodstream.

a- Tumor necrosis factor-α
Tumor necrosis factor-α is the principal mediator of the response to gramnegative bacteria (Shuster et al., 1993; Riollet et al., 2000) and may also play a
role in innate immune responses to other infectious agents (van den Berg et al.,
1999; Malazdrewich et al., 2001). Newly synthesized pro-TNF-α is first displayed
on the plasma membrane and then proteolytically cleaved in the extracellular
domain to release the mature TNF-α (Kriegler et al., 1988). The 17-kDa soluble
TNF-α is the mature form mediating biologic effects. The 26-kDa transmembrane
pro-TNF-α, however, is also active and has been shown to mediate the cytotoxic
effect of TNF-α through cell-to-cell contact (Kriegler et al., 1988).
Tumor necrosis factor-α synthesis can be stimulated in various cell types
by a wide range of stimuli. Although produced predominantly by monocytemacrophages, TNF-α is also made by other cells such as fibroblasts, epithelial
cells, mast cells, neutrophils, natural killer cells and many others (Wang and
Tracey, 1999). Exogenous and endogenous factors produced by bacteria,
viruses, parasites and tumors are capable of inducing cells to produce TNF-α
(Wang and Tracey, 1999). Lipopolysaccharide (LPS) is the classical inductor of
TNF-α synthesis in monocytes and macrophages through CD14, a specific LPS
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receptor (Wright et al., 1990). Paape et al. (1996) reported the presence of
CD14 on bovine mammary PMN and macrophages.
The activity of TNF-α is mediated through at least two types of cell surface
receptors, type I (TNFRI) and type II (TNFRII), which are present on virtually all
cell types (Hohmann et al., 1989). Most biologic activities of TNF-α are mediated
through TNFRI (Espevik et al., 1990), and involve increased rates of transcription
of particular target genes, often through activation of NFκB or AP-1 transcription
factors (Malinin et al., 1997).
When small quantities of TNF-α are produced, TNF-α acts locally as a
paracrine and autocrine regulator of leukocytes and endothelial cells. Principal
biological activities of TNF-α include activation of endothelial cells in the
vasculature to express new adhesion molecules that will facilitate neutrophil and
subsequently

monocyte

and

lymphocyte

migration.

Additionally,

TNF-α

stimulates macrophages and other cell types to secrete chemokines that
contribute to leukocyte recruitment, and also activates leukocytes to kill invading
microbes (Abbas et al., 1997).
When larger amounts of TNF-α are produced, TNF-α can enter the
circulation and have systemic effects. These include induction of fever by
increased synthesis of prostaglandins in the hypothalamus, stimulation of
macrophages and perhaps vascular endothelial cells to stimulate secretion of IL1 and IL-6, and stimulation of hepatocyte synthesis of acute phase proteins
(Baumann and Gauldie, 1994).
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The role of TNF-α as an inflammatory mediator during mastitis has been
studied extensively in E. coli and endotoxin induced mastitis (Shuster et al.,
1993; Shuster et al., 1996; Rainard and Paape, 1997; Blum et al., 2000; Riollet et
al., 2000; Paape et al., 2002). As a general rule, after E. coli or endotoxin
challenge, TNF-α concentrations increase sharply in the inflamed mammary
gland, peaking within 24 hours of initial challenge and decreasing sharply
afterwards (Shuster et al., 1997; Riollet et al., 2000; Paape et al., 2002).
Increased TNF-α concentration in infected mammary glands also correlates with
enhanced leukocyte migration from the bloodstream into the mammary gland and
with the onset of clinical signs of mastitis (Blum et al., 2000; Paape et al., 2002).
TNF-α is clearly associated with acute inflammation, but was not detected in
milk of cows with chronic S. aureus mastitis (Riollet et al., 2000).
The role of TNF-α during S. uberis mastitis has not been investigated.
Although different S. uberis strains have shown different pathogenicity (Hill,
1988; Oliver, personal communication), S. uberis mastitis tends to be less severe
than E. coli mastitis, although it can cause serious clinical infections.
Furthermore, S. uberis mastitis can be of long duration as opposed to E. coli
mastitis, which is usually eliminated by the animal within 5 to 6 days (Hill et al.,
1978; Lohuis et al., 1990; Shuster et al., 1996; Shuster et al., 1997).
Streptococcus uberis, as a gram-positive organism, is markedly different
from E. coli, and its antigenic determinants and virulence factors may likely elicit
different effector mechanisms of the inflammatory response. A study by Tissi et
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al. (1999) evaluated the role of TNF-α and other cytokines in a mouse model of
group B streptococcal arthritis. Interestingly, Tissi et al. (1999) found that TNF-α
was not detected in joints of mice injected with group B Streptococcus throughout
the challenge period, even when articular lesions were most frequent and severe.
These findings suggest that TNF-α is not involved in the pathogenesis of
streptococcal arthritis. It is possible that other streptococci such as S. uberis
stimulate similar inflammatory responses.

b- Interleukin-1
Interleukin-1 is the prototype ‘multifunctional’ cytokine, affecting nearly
every cell type, often in concert with TNF-α (Dinarello, 1999). The primary source
of IL-1 is the activated macrophage; however, many other cell types such as
epithelial cells and endothelial cells can produce IL-1. Specifically for the
mammary gland, it has been demonstrated that mammary epithelial cells can
produce IL-1 upon LPS stimulation (Boudjellab et al., 2000), and probably upon
other stimuli. There are two forms of IL-1, referred to as IL-1α and IL-1β, but their
biological activity is identical. Most of the IL-1 activity found in the circulation is
IL-1β (Abbas et al., 1997). Two different membrane receptors have been
characterized for IL-1, both of which belong to the Ig superfamily, referred to as
type I and type II receptors. The type I receptor has slightly higher affinity for IL1β, and mediates most of the IL-1 responses (Sims et al., 1993).
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When produced in low amounts, IL-1 acts locally on endothelial cells to
promote coagulation and to increase expression of surface molecules that
mediate leukocyte adhesion. Interleukin-1 does not directly activate leukocytes,
but causes macrophages and endothelial cells to synthesize chemokines that do
activate leukocytes, such as IL-6. When secreted into the circulation, IL-1 shares
with TNF-α the ability to cause fever, induce hepatic synthesis of acute phase
proteins and initiate metabolic wasting (Abbas et al., 1997).
The dynamics of IL-1 production have also been studied in detail during E.
coli and endotoxin mastitis (Shuster et al., 1993; Shuster et al., 1996; Shuster et
al., 1997; Riollet et al., 2000). Interleukin-1 concentrations increased sharply and
usually peaked shortly after TNF-α concentrations (Shuster et al., 1997; Riollet et
al., 2000). Similarly to TNF-α, no information exists on IL-1 production during S.
uberis mastitis.

c- Interleukin-8
Interleukin-8 belongs to the chemokine family of cytokines. Chemokines
are small molecules, approximately 8 to 10 kDa in size, characterized by their
strong chemotactic ability (Oppenheim et al., 1991; Baggiolini et al., 1994).
Interleukin-8 has been established as a principal chemotactic factor directing
neutrophil recruitment to and activation at the inflammatory focus (Harda et al.,
1994). Activated monocytes and macrophages appear to be the predominant
cellular sources of IL-8, but several nonimmune cells, such as epithelial cells can
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also produce this chemokine (Eckmann et al., 1993). Recently, Boukjellab et al.
(1998) reported IL-8 production by bovine mammary epithelial cells following LPS
stimulation. Barber and Yang (1998) indicated presence of IL-8 in mammary
secretions from cows with mastitis and reported that the chemotactic ability of
those secretions was due to IL-8.
Interleukin-8 is expressed at high levels in milk from cows with coliform
mastitis (Riollet et al., 2000). Interleukin-8 production begins more slowly than
TNF-α and IL-1 and persists longer (Shuster et al., 1997; Riollet et al., 2000).
Barber and Yang (1998) detected IL-8 activity in mammary secretions from a cow
clinically infected with S. aureus. The role of IL-8 during S. uberis mastitis,
however, has not been determined.

SUMMARY AND STATEMENT OF THE PROBLEM

Bovine mastitis is the most common and expensive disease affecting dairy
cows throughout the world. Studies have shown that as the prevalence of
contagious mastitis pathogens was reduced, the proportion of IMI by
environmental mastitis pathogens increased markedly. Streptococcus uberis is
an environmental pathogen that accounts for a significant proportion of clinical
and subclinical mammary gland infections worldwide and is not readily controlled
by current mastitis control measures. The pathogenesis of S. uberis mastitis is
incompletely understood. Most pathogenesis studies on bovine mastitis have
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been conducted using E. coli or endotoxin experimental challenge models; these
studies have elucidated the role of blood and milk leukocytes as well as several
acute phase inflammatory mediators in the development of E. coli mastitis. No
information exists on the role of inflammatory mediators during S. uberis
infection. Therefore, the objective of this study is to evaluate the dynamics of
leukocytes and cytokines during experimentally induced S. uberis mastitis. A
better understanding of the pathogenesis of S. uberis mastitis will facilitate
development of more efficient control strategies that will minimize economic
losses and improve animal health and milk quality.
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Chapter 3
DYNAMICS OF LEUKOCYTES AND CYTOKINES DURING
EXPERIMENTALLY-INDUCED STREPTOCOCCUS UBERIS
MASTITIS

INTRODUCTION

Bovine mastitis continues to be the most economically devastating
disease affecting the dairy industry (National Mastitis Council, 1996). Of the
many bacterial pathogens capable of causing mastitis, environmental pathogens
have become increasingly problematic, particularly in herds that have
successfully controlled contagious pathogens (Oliver and Mitchell, 1984; Oliver,
1988; Todhunter et al., 1995). Among environmental pathogens, Streptococcus
uberis is one of the most prevalent, accounting for a significant proportion of
subclinical and clinical intramammary infections (IMI) in both lactating and
nonlactating cows (Smith et al., 1985; Oliver, 1988; Todhunter et al., 1995;
Jayarao et al., 1999; Phuektes et al., 2001).
Acceptance and widespread application of mastitis control practices
devised in the 1960’s has led to considerable progress in the control of
contagious mastitis pathogens. However, these procedures have been less
effective against environmental mastitis pathogens. One possible approach to
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controlling environmental mastitis involves manipulation of host defense
mechanisms. This approach requires knowledge of host and pathogen factors
involved in the development and establishment of IMI as well as defense
mechanisms within the udder and ways to enhance these mechanisms (Calvinho
et al., 1998). However, the pathogenesis of S. uberis mastitis is incompletely
understood. The role of polymorphonuclear neutrophils (PMN) has been well
established in the defense against Escherichia coli (Hill et al., 1978) and
Staphylococcus aureus infection of the bovine mammary gland (Schalm et al.,
1976). This has not been established for the control of IMI by S. uberis.
Furthermore, to our knowledge, a description of inflammatory mediator
production during S. uberis mastitis does not exist in the literature. The role of
cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and
interleukin-8 (IL-8) have been studied extensively during E. coli and endotoxininduced mastitis (Shuster et al., 1993; Shuster et al., 1996; Rainard and Paape,
1997; Blum et al., 2000; Riollet et al., 2000; Paape et al., 2002). No information
exists on the role of cytokines during S. uberis mastitis. Streptococcus uberis, a
prevalent gram-positive mastitis pathogen, is markedly different from E. coli, and
its antigenic determinants and virulence factors likely elicit different effector
mechanisms of the inflammatory response. To gain a better understanding of the
pathogenesis of S. uberis mastitis, the objective of the present study was to
evaluate the dynamics of leukocytes and cytokines, if produced, during
experimentally induced S. uberis mastitis.
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MATERIALS AND METHODS

Experimental herds
Lactating cows from two dairy research herds of The University of
Tennessee were used in this study. The Dairy Experiment Station (DES)
research herd in Lewisburg, TN consists of approximately 170 lactating Jersey
cows. The herd is Streptococcus agalactiae-negative and has a low prevalence
of S. aureus but experiences mastitis problems caused by environmental
pathogens,

in

particular

S.

uberis,

Streptococcus

dysgalactiae

subsp.

dysgalactiae and Gram-negative bacteria. Cows in the DES research herd are
milked twice daily in a 12-stall trigon milking parlor equipped with automatic
milking machine take-offs (Surge, Babson Bros., Oak Brook, IL, USA). Milking
machines are backflushed (Surge Backflush II, Babson Bros.) with water after
removal from cows. Premilking and postmilking teat disinfection are practiced.
Animals are fed rations consistent with stage of lactation and described in the
standard operating procedures of the site. Water is provided ad libitum. Lactating
cows are housed in free stalls at ambient temperature. Stalls are bedded with
dairy waste solids separated from a manure slurry (Alfa-Laval, Inc., Kansas City,
MO, USA). Cows are pastured 4 to 6 hours per day when weather and pasture
permit. Bovine somatotropin (Posilac, Monanto, St. Louis, MO, USA) is used as a
management tool to increase milk production of lactating dairy cows after peak
lactation. All cows are dried off approximately 6 to 8 weeks before expected
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calving and all mammary glands of cows are infused with an antibiotic
preparation approved for use in nonlactating cows following the last milking of
lactation.
The Middle Tennessee Experiment Station (MTES) dairy research herd in
Spring Hill, TN is composed of approximately 150 lactating Holstein cows. The
herd is S. agalactiae-negative but experiences mastitis problems caused
by S. aureus and environmental pathogens, in particular S. uberis. Cows
in the MTES dairy research herd are milked twice daily in a double-eight
parallel parlor equipped with a DeLaval milking machine system (De
Laval) with automatic milking machine take-offs. Premilking- and postmilking teat
disinfection are practiced. Milking equipment is evaluated routinely and
maintained per manufacturer's recommendation. Animals are fed rations
consistent with stage of lactation and as described in the standard operating
procedures of the site. Water is provided ad libitum. Lactating cows are housed
in

free

stalls

at

ambient

temperature.

Stalls

are

bedded

with

sawdust. Lactating cows are allowed on pasture for exercise for 4 hours per
day when weather permits. Bovine somatotropin (Posilac, Monanto) is used as
a management tool to increase milk production of lactating dairy cows after
peak lactation. All cows are dried off approximately six to eight weeks
before expected calving and all mammary glands of cows are infused with
antibiotic preparations approved for use in nonlactating following the last milking
of lactation.
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Animals
Five clinically healthy Holstein cows from the Middle Tennessee Dairy
Experiment Station and 5 clinically healthy Jersey cows from the Dairy
Experiment Station were used in this experiment. All cows were approximately
11-38 days in milk, in their 2nd lactation, and had not been exposed previously to
S. uberis. Each cow was challenged by intramammary inoculation in 2 uninfected
mammary glands. One non-challenged mammary gland from each cow served
as a within-cow negative control. Selection of uninfected mammary glands for the
experiment was based on microbiological examination of mammary secretions
14 and 7 days prior to challenge and SCC of <2.5 X 105 cells/ml.

Bacterial suspension and challenge exposure
Streptococcus uberis UT888, isolated originally from a cow with clinical
mastitis, was used in the experimental challenge study. Stock bacterial cultures
stored at –80°C were thawed, plated on a trypticase soy agar plate
supplemented

with

5%

defibrinated

sheep

blood

(Beckton

Dickinson

Microbiology Systems, Cockeysville MD, USA), and incubated overnight at 37ºC
in a 5% CO2 incubator. Approximately two to five colonies were then subcultured
at 37°C in Todd Hewitt Broth (Difco, Detroit, MI, USA) for 7 hours to a
concentration of approximately 5X108 colony forming units (CFU)/ml. Bacterial
cultures were then diluted in sterile phosphate-buffered saline (PBS).
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Inoculation procedure
Within 0.5 hours after the afternoon milking, teats of cows were cleaned
thoroughly with individual disposable paper towels, and teat ends sanitized with
swabs containing isopropyl alcohol. The bacterial suspension was infused using
sterile disposable syringes fitted with sterile disposable teat cannulas. Five ml of
inoculum containing 6,650 CFU (Jersey cows) or 10,500 CFU (Holstein cows) of
S. uberis in sterile PBS were infused into two uninfected mammary glands of
each cow. The infused inoculum was massaged upward into the gland cistern.
Teats were immersed in a postmilking teat disinfectant when the above
procedure had been completed. The actual number of bacteria infused into
mammary glands was determined by viable plate count on blood agar before and
after inoculation.

Milk sampling regimen
Milk samples were collected at 0, 12, 18, 24, 36, 42, 48, 60, 66, 72, 84, 90, 96,
108, 114, 120, 144 and 168 hours after challenge (Table 3). When the sampling
time point coincided with milking, samples were collected before cows were
milked. Samples of foremilk for microbiological examination were collected
aseptically as described by Oliver et al. (1994). Before sample collection, teats of
cows were cleaned thoroughly with individual disposable paper towels, and teat
ends were sanitized with swabs containing isopropyl alcohol. Samples were
collected in sterile tubes and stored at –20ºC until analysis. Samples for
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Table 3. Sampling schedule for cows challenged with Streptococcus uberis.

Hours

Micro

0
12
18
24
36
42
48
60
66
72
84
90
96
108
114
120
144
168

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

1

2

SCC
(challenged
mammary
glands)
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

2

SCC
(control
mammary
glands)
X
X
X
X
X
X
X
X

3

Cytokines
(challenged
mammary
glands)
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

1

3

Cytokines
(control
mammary
glands)
X

Evaluation
4
of animals

Blood

X
X

X

X
X

X

X
X

X

X
X

X

X
X

X
X
X

X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

Milk for microbiological analysis, all mammary glands sampled.
Milk for determination of the number of somatic cells.
Milk for cytokine analysis.
4
Rectal temperature, physical palpation of the udder and strip cup examination of mammary secretions.
2
3
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determination of numbers of somatic cells (approximately 30 ml) were collected
in plastic snap cap vials (Capitol Vial Co.) preloaded with Bronopopl-B as
preservative. Samples for determination of numbers of somatic cells were
shipped via overnight courier to the Dairy Herd Improvement Association (DHIA)
Laboratory, The University of Tennessee, Knoxville, TN, for analysis. Milk
samples for cytokine quantification (50 ml) were collected in sterile 50 ml plastic
tubes. Samples were refrigerated at 4ºC immediately after collection, shipped via
overnight courier and whey was obtained as described below upon arrival to the
Lactation/Mastitis Laboratory at The University of Tennessee, Knoxville, TN.

Evaluation of animals
Clinical assessment of all animals was performed before experimental
challenge and at 0, 12, 18, 24, 36, 42, 48, 60, 66, 72, 84, 90, 96, 108, 114, 120,
144 and 168 hours after challenge. Rectal temperatures were determined at
similar time points. Clinical status of all mammary glands and appearance of milk
was evaluated using the following scheme:
Milk: 1= normal, 2= a few flakes, 3= small slugs, 4= large slugs/clots, 5=
stringy/watery, and 6= bloody.
Udder: 1= normal, 2=slight swelling, 3= moderate swelling, 4= severe
swelling, 5= scar tissue, and 6= edema.

45

Cows that developed clinical mastitis (defined as visible abnormalities in
the mammary gland and/or milk) were monitored closely and antibiotic treatment
was initiated after day 7 post-challenge or earlier if required. An IMI was defined
as a challenged mammary gland where S. uberis was isolated at 2 or more
occasions during the one week experimental period.

Determination of numbers of somatic cells in milk
Numbers of somatic cells in milk for each challenged and control
mammary gland were determined by DHIA personnel at The University of
Tennessee, Knoxville, TN, with a Somacount 300 cell counter (Bentley
Instruments, Chaska, MN, USA).

Bacteriological examination of mammary gland foremilk samples
Milk samples were examined following procedures recommended by the
National Mastitis Council and essentially as described by Oliver et al. (1994).
Thawed samples of mammary secretion were mixed thoroughly by vortexing, and
10 µl of each sample were spread onto one quadrant of a trypticase soy agar
plate supplemented with 5% defibrinated sheep blood (Beckton Dickinson
Microbiology Systems). Plates were incubated at 37ºC and bacterial growth was
observed and recorded at 24-h intervals for three days. Bacteria were identified
tentatively according to colony morphologic features, hemolytic characteristics,
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and catalase test. Isolates identified presumptively as staphylococci were tested
for coagulase by the tube coagulase method. Isolates identified presumptively as
streptococci were evaluated initially for growth in 6.5% NaCl, hydrolysis of
esculin and CAMP reaction. Streptococcal organisms were identified to the
species level using the API 20 Strep System (bioMerieux, Vitek Inc., Hazelwood,
MO, USA) upon first and last isolation of the organism from experimentally
infected mammary glands. Streptococcal organisms isolated between the first
and last isolation were identified as S. uberis by growth in 6.5% NaCl, hydrolysis
of esculin and CAMP reaction. When necessary, milk samples were diluted in
PBS and four-10 µl drops of each dilution were plated on trypticase soy agar to
determine the number of S. uberis per ml of milk.

Preparation of whey samples
Whole milk samples from challenged and control mammary glands of
cows in the MTES herd were centrifuged at 48,000 x g for 40 minutes at 4ºC.
Whey was harvested between the supernatant (fat layer) and the infranatant
(casein and cells). Milk samples from cows in the DES herd were centrifuged at
27,000 x g for 30 minutes at 4ºC, the fat layer was removed and the sample pH
was decreased to 4.5 by addition of glacial acetic acid. Samples were centrifuged
at 27,000 x g for 30 minutes at 4ºC to precipitate casein and the supernatant was
removed by filtration through gauze sponges. The pH was restored to 6.5-7.5
immediately before cytokine analysis by addition of NaOH. All samples were
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stored at –80ºC until cytokine analysis by enzyme-linked immunosorbent assay
(ELISA).

IL-1β ELISA
Bovine IL-1β was measured by ELISA using commercial antibodies
against ovine IL-1β (Serotec Inc., Raleigh, NC, USA), with the coating
monoclonal antibody and the detecting antiserum diluted as suggested by the
manufacturer. Flat bottom 96-well plates (Corning Inc., Corning, NY, USA) were
coated with 100 µl of monoclonal antibody anti-ovine IL-1β at a concentration of 5
µg/ml diluted in PBS and incubated at 4ºC overnight. Plates were washed three
times with PBS-0.01% Tween (PBST), and 200 µl of 5% bovine serum albumin
(BSA) in PBST were added to each well to block nonspecific protein binding
sites. Plates were incubated for 1 hour at 37ºC. After washing plates as before,
100 µl of whey were loaded into each well, together with serial 2-fold dilutions of
purified rbIL-1β (10 ng/ml to 0.31 ng/ml) for use as a standard (generously
provided by Susan Dunney, Fort Dodge Animal Health, Princeton, NJ, USA).
After incubation for 1 hour at 37ºC, plates were washed 3 times and 100 µl of
rabbit anti-ovine IL-1β diluted 1:500 in PBST-1%BSA were added to each well.
Plates were incubated for 1 hour at 37ºC, washed 3 times and 100 µl of goat
anti-rabbit

IgG

conjugated

with

horseradish

peroxidase

(Jackson

Immunoresearch, West Grove, PA, USA) diluted 1:20000 in PBST-1%BSA were
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added to each well. Plates were incubated for 1 hour at 37ºC, washed 3 times
and 100 µl of the enzyme substrate, 52 mM 2,2’-azino-bis-(3-etylbenzthiazoline6-sulfonic acid) (Sigma, St. Louis, MO, USA) in 0.1M citrate buffer (pH 4.2) with
0.075% hydrogen peroxide were added to each well. Absorbance was read at
405 nm with an ELISA plate reader (Bio-Tek, Winooski, VT, USA) after about 30
minutes at room temperature. Wells that received normal pooled whey from
uninfected mammary glands served as blanks. Bovine IL-1β concentrations were
calculated by referring to a standard curve. All samples were assayed in
triplicate.

TNF-α ELISA
Concentrations of TNF-α in whey were quantified as described by Paape
et al. (2002) with slight modifications. Wells were coated with 100 µl of
monoclonal antibody anti-bovine TNF-α (2C4 1D3, generously provided by Dr.
Max Paape, ARS, USDA, Beltsville, MD, USA) diluted 1:1000 in carbonatebicarbonate buffer (pH 9.6). After incubation overnight at 4ºC, plates were
washed 3 times with PBST and 200 µl of PBS-1%BSA were added to each well
to block nonspecific protein binding sites. Plates were incubated for 1 hour at
37ºC in a humidified chamber. After washing as before, 100 µl of appropriate
dilutions of samples to be tested were added to each well and incubated at 37ºC
for 2 hours. Plates were then washed 3 times and 100 µl of rabbit serum antiTNF-α (generously provided by Dr. Ted Elsasser, ARS, USDA, Beltsville, MD,
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USA) diluted 1:5000 in PBST-1%BSA were added to each well. Plates were
incubated for 2 hours at 37ºC in a humidified chamber. After washing the plates
as before, 100 µl of goat anti-rabbit IgG conjugated with horseradish peroxidase
(Jackson Immunoresearch) diluted 1:20000 in PBST-1%BSA were added to
each well and incubated for 2 hours at 37ºC in a humidified chamber.
Horseradish peroxidase activity was detected by addition of the enzyme
substrate, 52 mM 2,2’-azino-bis-(3-etylbenzthiazoline-6-sulfonic acid; Sigma) in
0.1M citrate buffer (pH 4.2) with 0.075% hydrogen peroxide to each well.
Absorbance was read at 405 nm with an ELISA plate reader (Bio-Tek) after
about 30 minutes at room temperature. Wells that received normal pooled whey
from uninfected mammary glands served as blanks. Two-fold dilutions of cell
culture supernatant from LPS stimulated monocytes with a known concentration
of TNF-α were used to establish a standard curve. All samples were assayed in
triplicate.

IL-8 ELISA
Concentrations of IL-8 in whey were measured by use of a commercial
ELISA kit (R&D Systems, Minneapolis, MN, USA) essentially as described by the
manufacturer. Fifty microliters of standard containing known amounts of
recombinant human IL-8 (rhIL-8) or samples were added in duplicate to wells
precoated with monoclonal antibody against rhIL-8. A polyclonal antibody antirhIL-8 conjugated with horseradish peroxidase was also added to wells. Samples
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were incubated for 3 hours at room temperature, washed 6 times and 200 µl of
the enzyme substrate tetramethylbenzidine were added to wells. Samples were
incubated for 30 minutes at room temperature in the dark, and the enzymatic
reaction was stopped by addition of 2N sulfuric acid. The optical density at
450/562 nm was determined with an ELISA plate reader (Bio-Tek). The IL-8
concentration in samples was determined by comparing absorbance obtained
with that of the standard curve.

Blood samples
Blood was collected in Holstein cows only. Blood samples for leukocyte
total counts and adhesion molecule expression were collected in vacutainer
tubes containing 2X Acid Citrate Dextrose (ACD, pH 6.1) in a 20% vol/vol as
anticoagulant by puncture of the tail vein. Samples were collected immediately
prior to bacterial challenge and at the same time milk samples were taken. Blood
was shipped via overnight courier and processed immediately upon arrival at the
laboratory.

Leukocyte counts of whole blood
Total leukocyte counts on blood were determined manually with a
hemocytometer after lysing erythrocytes with a Unopette microcollection system
kit (Beckton Dickinson and Co., Franklin Lanes, NJ, USA).
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Neutrophil isolation
Neutrophils were isolated as described previously (Aarestrup et al., 1994)
with some modifications. Blood was centrifuged at 860 x g for 30 minutes at
15ºC, and the plasma and buffy coat were discarded. Neutrophils were isolated
from the remaining erythrocytes by adding an equal volume of double-distilled
water for 30 seconds and then by adding a 3X concentration of RPMI 1640
medium (Sigma) to regain isotonicity of the solution. Remaining cells were
washed twice with Hank’s balanced salt solution (Sigma) and resuspended in
FACS solution (0.15M PBS, pH 7.2; 2% heat inactivated fetal bovine serum;
0.03% sodium azide) to a final concentration of 107 cells/ml.

Neutrophil adhesion molecule expression
Indirect immunofluorescent analysis of β2 integrin expression on
neutrophils in blood samples was performed by measuring CD18 and CD11b
expression using murine monoclonal antibodies and fluorescein-conjugated
antibody to mouse IgG. Additionally, expression of selectin CD62 on neutrophils
was evaluated. Fifty microliters of neutrophil suspension were added to 96-well
round bottom microtitre plates with 50 µl of FACS solution (negative control),
monoclonal antibodies to bovine CD11b (BAQ147A, VMRD Inc., Pullman, WA,
USA), bovine CD18 (BAQ30A, VMRD Inc.) or bovine L-selectin (DU1-29, VMRD
Inc.). Plates were incubated at 4ºC for 30 minutes, washed 3 times with FACS
solution, and 100 µl of goat anti-mouse IgG fluorescein conjugate (Calbiochem,
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La Jolla, CA, USA) were added to each well. Samples were incubated at 4ºC for
30 minutes, washed as before, and resuspended in 2% formaldehyde in 0.15M
PBS. Samples were stored at 4ºC in the dark until assayed by flow cytometry.

Flow cytometry analysis
Fluorescence was measured with a FACScan flow cytometer (Beckton
Dickinson Immunocytommetry Systems, San Jose, CA, USA). Dot plots were
gated for PMN. Leukocytes were assayed for size by forward scattering and for
granularity by side scattering. Expression of cell adhesion molecules (i.e., mean
fluorescence intensity (MFI)) was calculated after plotting fluorescence of
histograms. Fluorescence associated with PMN incubated with FITC-goat antimouse IgG secondary antibody in the absence of anti-CD18 or anti-CD11b was
considered the control for nonspecific fluorescence. Data were expressed as
relative fluorescence intensity units after subtraction of nonspecific (control)
fluorescence.

Statistical analysis
Analysis of variance was done with mixed models using SAS software
(SAS 8.02, SAS Institute Inc, Cary, NC). A randomized block design with
replication was used to determine effect of infection with S. uberis over time.
When necessary, data were converted to log10 to maintain a normal distribution
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for statistical analysis. Data are presented as least square means with
associated standard error. Statistical significance was declared at P<0.05, and a
trend toward significance was declared at P<0.10.

RESULTS

Experimental challenge and infection with Streptococcus uberis
Five Holstein cows and 5 Jersey cows were challenged with S. uberis in 2
uninfected mammary glands. Seven cows became infected in both challenged
mammary glands, 2 cows became infected in 1 of 2 challenged mammary
glands, and 1 cow did not become infected in either challenged mammary gland.
There were no significant differences between breeds in response to challenge
with S. uberis for all parameters evaluated (P>0.05). Therefore, data from all
cows were combined for subsequent analysis.

Clinical signs
Following bacterial challenge with S. uberis, 16 of 20 challenged
mammary glands developed clinical mastitis. Significant changes in mammary
and milk scores were first observed at 84 hours after challenge and peaked at
144 hours after challenge (P<0.01; Table 4). Infected mammary glands exhibited
swelling and mammary secretions were obviously abnormal, with presence of
clots and slugs. Local symptoms were accompanied by a mild systemic
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Table 4. Clinical signs in cows challenged with Streptococcus uberis.

Hours
4

0
Temperature (ºC)

12

18

24

36

42

48

60

66

72

84

90

96

108

114

120

144

168

SE

CI1 (n=9)
CU2 (n=1)

38.6
38.9

38.7
38.5

39.3
39.2

38.9
39.1

38.5
39.6

39.1
39.5

38.7
38.9

38.6
38.9

39.2
38.8

39.2
38.1

39.0
38.0

39.7
38.4

39.4
38.8

38.9
38.2

39.3
38.6

38.3
38.8

38.3
38.4

0.3

38.7
38.6

Mammary score
CI (n=16)
CU (n=4)
Control3 (n=9)

1a
1
1

1a
1
1

1a
1
1

1a
1
1

1.19a
1
1

1.19a
1
1

1.5 a
1
1

1.69 b
1
1

2.44 b
1
1

2.63 b
1
1

3.0 b
1
1

3.13 b
1
1

2.88 b
1
1

0.18

1a
1
1

1a
1
1

1a
1
1

1a
1
1

1a
1
1

1.13a
1
1

1.56a
1
1

2.06b
1
1

2.18b
1
1

2.63b
1
1

2.5b
1
1

3.63b
1
1

3.13b
1
1

0.21

Milk score
CI (n=16)
CU (n=4)
Control (n=9)
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1

Challenged infected mammary glands.
Challenged uninfected mammary glands.
Control unchallenged mammary glands.
4
SE= standard error of the mean.
a,b,c
Values within the same row with different superscript differ (P<0.01).
2
3

response, evidenced by an increase in rectal temperature in all infected cows.
Rectal temperatures did not peak at a similar time point in all cows. Mean
maximum rectal temperature was 40.7±0.3ºC. Unchallenged control mammary
glands and 4 challenged mammary glands did not become infected and did not
exhibit clinical signs. Based on severity of clinical signs, 3 mammary glands
received antimicrobial therapy at 120 hours, 8 mammary glands received
antimicrobial therapy at 144 hours and 4 mammary glands received antimicrobial
therapy 168 hours after challenge.

Enumeration of bacteria and somatic cells
For the first 42 hours after intramammary inoculation, S. uberis was found
in very low numbers in challenged infected mammary glands (Figure 1). Since
Holstein cows received a slightly higher inoculum dose than Jersey cows, S.
uberis was isolated at earlier time points in Holstein cows (Table 5). However,
bacterial numbers in those isolations were very small (Appendix). Numbers of S.
uberis in milk increased significantly (P<0.05; Figure 1) by 48 hours after
challenge. Between 48 hours and 120 hours after challenge, the time point at
which maximal bacterial concentration was reached (5.03 log10±0.79 CFU/ml;
P<0.01), numbers of S. uberis in mammary secretions increased 1,500-fold. This
occurred in spite of massive leukocyte infiltration from the bloodstream into
challenged mammary glands (Figure 2). Significant increases in bacterial
numbers coincided with appearance of clinical signs (Table 4). After reaching a
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6

CFU/ml (log10)/ml

5

*
*

4

*
*

*
*

*
*

*
*

*
*

*
*

*
*
*
*

*
*

3

*

*

2

1

0
0

12

18

24

36

42

48

60

66

72

84

90

Hours

96 108 114 120 144 168
Challenged infected quarters (n=16)
Challenged uninfected quarters (n=4)
Control quarters (n=9)

Figure 1. Enumeration of Streptococcus uberis in milk (CFU/ml (log10)) from
mammary glands of cows challenged with S. uberis. Data are means ± SEM.
Asterisks

indicate

significant

differences

(*P<0.05;**P<0.01).
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from

prechallenge

values

Table 5. Number of infected mammary glands shedding Streptococcus uberis at
different time points after challenge.

Hours after
challenge
0
12
18
24
36
42
48
60
66
72
84
90
96
108
114
120
144
168
1

Number of challenged infected
mammary glands shedding S. uberis
Holstein cows1
Jersey cows2
(n=8)
(n=8)
0
0
7
0
7
0
6
0
3
4
4
5
3
6
6
7
6
8
6
7
6
8
7
8
8
8
8
8
8
8
8
8
7
5
3
6

Holstein cows received an inoculum dose of 10,500 CFU.
2
Jersey cows received an inoculum dose of 6,650 CFU.
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7.5

Somatic cells (log 10)/ml

7

6.5

*
*
*

6

*
*
*

*
*
*

5.5
*
*

*
5

*
*
*

*
*
*

*
*
*

*
*

*
*
*

*
*

*
*
*

*
*
*

*
*

* *
* *
* *

*
*
*

*
*

*
*
*

*
*

*

*

*
*

*
*
*

*
*
*

*
*
*

*
*
*

*
*

4.5

4
0

12

18

24

36

42

48

60

66

72

84

90

96 108 114 120 144 168
Challenged infected quarters (n=16)
Challenged uninfected quarters (n=4)
Control quarters (n=9)

Hours

Figure 2. Number of somatic cells (log10/ml) in milk from mammary glands of
cows challenged with Streptococcus uberis. Data are means ± SEM. Asterisks
indicate significant differences from prechallenge values (*P<0.05;**P<0.01;
***P<0.001).
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peak concentration at 120 hours after challenge, bacterial numbers began to
decline; this coincided with initiation of antibiotic therapy in 15 of the 16 infected
mammary glands between 120 and 168 hours after challenge. Streptococcus
uberis was not isolated from 4 challenged mammary glands that did not become
infected, or from unchallenged control mammary glands.
Leukocyte recruitment to infected mammary glands, as indicated by an
increase in the number of somatic cells in milk, began at 18 hours after challenge
(P<0.001; Figure 2) and continued throughout the sampling period. Before
challenge, the number of somatic cells averaged 4.27 log10 /ml; 42 hours after
challenge, even when no clinical signs were observed and no bacterial growth
had been detected, number of somatic cells in milk increased 100-fold (6.3±0.18
log10/ml) and continued to increase to a maximum number of 6.76±0.18 log10/ml
at 120 hours. Challenged mammary glands which did not become infected (n=4)
exhibited a significant increase in number of somatic cells (P<0.01; Figure 2).
However, the magnitude of the increase was not as great as challenged
mammary glands that became infected. No significant changes in the number of
somatic cells in milk from unchallenged control mammary glands were detected.

Leukocyte counts in peripheral blood
Blood leukocyte counts varied greatly from cow to cow; however, there was a
significant decrease in total blood leukocyte counts at 72 hours after challenge
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(P=0.05; Figure 3). After that, blood leukocyte counts remained suppressed and
did not return to baseline levels until 168 hours after challenge.

Tumor necrosis factor-α
During S. uberis experimental infection, TNF-α concentrations in whey
from infected mammary glands increased significantly by 66 hours following
bacterial challenge (P<0.01; Figure 4), and remained significantly elevated
throughout the remainder of the sampling period. Peak TNF-α concentrations
were observed at 120 hours after challenge (461±76 pg/ml). One of four
challenged, uninfected mammary glands exhibited a slight increase in TNF-α
concentrations; the remainder of the challenged, uninfected mammary glands
had TNF-α concentrations below the detection limits of the assay. Only trace
amounts of TNF-α were detected in whey from prechallenge samples and in
whey from unchallenged control mammary glands.

Interleukin-1β
Concentrations of IL-1β in whey from mammary glands experimentally infected
with S. uberis increased significantly by 66 hours after bacterial challenge
(P<0.01; Figure 5). Concentrations of IL-1β fluctuated considerably from 66 to
144 hours after challenge, however IL-1β concentrations during these times were
still significantly (P<0.01) higher than prechallenge concentrations. Highest IL-1β
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Figure 3. Leukocytes in blood (cells/ml (log10)) from cows experimentally infected
with Streptococcus uberis (n=9). Data are means ± SEM. Asterisks indicate
significant differences from prechallenge values (*P=0.05).
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Figure 4. Concentrations of tumor necrosis factor-α (TNF) in whey from
mammary glands challenged with Streptococcus uberis. Data are means ± SEM.
Asterisks indicate significant differences from prechallenge values (*P<0.05;
**P<0.01).
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Figure 5. Concentrations of Interleukin-1β (IL-1) in whey from mammary glands
challenged with Streptococcus uberis. Data are means ± SEM. Asterisks indicate
significant differences from prechallenge values (*P<0.05; **P<0.01).
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concentrations were observed at 90 hours after bacterial challenge (2.97±0.53
ng/ml). The 4 challenged, uninfected mammary glands exhibited an increase in
IL-1β concentrations, and the pattern appeared to be similar to that of challenged
infected mammary glands. However, the increase in IL-1β concentrations in
challenged uninfected mammary glands was not significant (P>0.05). Very low
concentrations of IL-1β were detected in control unchallenged mammary glands.

Interleukin-8
The concentration of IL-8 in whey was measured at all time points in
Holstein cows and daily in Jersey cows. The concentration of IL-8 was
significantly elevated in mammary secretions from challenged infected mammary
glands at 66 hours after bacterial challenge (P<0.01; Figure 6). Concentrations of
IL-8 fluctuated considerably throughout the remainder of the experimental period.
Peak IL-8 concentrations (34.6±6.8 pg/ml; P<0.001) were observed at 120 hours
after challenge. No IL-8 was detected in challenged, uninfected mammary glands
or in unchallenged control mammary glands.

Adhesion molecule expression on blood neutrophils
Adhesion receptor expression of CD11b, CD18 and CD62 was measured
in Holstein cows only and is shown in Table 6. Expression of CD11b, the α-chain
from the Mac-1 integrin, tended to show a slight upregulation at 84, 90 and 114
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Figure 6. Concentrations of interleukin-8 (IL-8) in whey from mammary glands
challenged with Streptococcus uberis. Data are means ± SEM. Asterisks indicate
significant differences from prechallenge values (*P<0.05; **P<0.01).
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Table 6. Mean fluorescence intensity (MFI) of CD11b, CD18 and CD62 adhesion
molecules on blood polymorphonuclear leukocytes following experimental
challenge with Streptococcus uberis.

Hours
0
12
18
24
36
42
48
60
66
72
84
90
96
108
114
120
144
168
SE3

MFI1
CD18
70.8a
61.3a
73.4a
66.4a
70.1a
66.8a
84.8b
73.3a
78.0a
66.3a
74.2a
76.3a
48.9c
44.2c
42.9c
42.6c
36.8c
31.4c
5

CD11b2
4.6a
6.7a
4.9a
7.1a
6.7a
6.3a
5.7a
4.8a
6.0a
7.1a
7.6b
8.6b
6.4a
5.5a
10.0b
5.4a
4.8a
4.8a
1.3

a,b,c

CD62
5.5a
5.8a
4.3a
6.3a
4.7a
3.7a
4.9a
4.9a
8.1a
6.9a
5.3a
6.9a
6.7a
15.2b
8.7a
4.2a
4.5a
5.1a
1.7a

Values within the same column with different superscript differ (P<0.05).
Mean fluorescence intensity (MFI) was measured by flow cytometry.
2
a,b,c
MFI for CD11b showed a trend toward significance (P=0.1).
Values within this column with
different subscript differ (P<0.05) after analysis through specific contrasts.
3
SE=standard error of the mean.
1
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hours after challenge (P=0.1). When these data were evaluated through specific
contrasts, CD11b expression was significantly higher (P<0.05) at 84, 90 and 114
hours after challenge. The mean fluorescence intensity for CD18, the β-chain of
the Mac-1 integrin, increased 20% by 48 hours after experimental challenge
(P<0.05). This was followed by a sharp decrease in CD18 MFI 96 hours after
challenge which continued until the end of the sampling period at 168 hours after
challenge (P<0.01). Expression of CD62 fluctuated somewhat after bacterial
challenge, and at 108 hours after challenge a significant increase in CD62
expression was observed (P<0.05).

Correlation coefficients
A moderate positive correlation was observed between concentrations of
TNF-α, IL-1β and IL-8 in whey, bacterial and somatic cell numbers and the
presence of clinical signs of mastitis and from challenged infected mammary
glands (Table 7).

DISCUSSION

Streptococcus uberis is an environmental mastitis pathogen that accounts
for a significant proportion of IMI in lactating and nonlactating dairy cows. The
present study was conducted with cows in early lactation, a time when mammary
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Table 7. Correlation coefficients between different clinical and bacteriological
parameters of infection during experimental Streprococcus uberis mastitis.

IL-1β
5

TNFα
IL-1β
IL-8
Mammary
score
Milk score
Temperature
Micro

b

0.62

1

2

IL-8

b

0.63
b
0.56

Correlation coefficients
Mammary Milk
Temperature
score
score
b
b
b
0.53
0.41
0.35
b
b
b
0.52
0.50
0.23
b
b
b
0.47
0.42
0.24
b
a
0.82
0.11
a

-0.14

1

IL-1β= interleukin-1β
IL-8= interleukin 8
3
Micro= enumeration of Streptococcus uberis in milk
4
SCC= number of somatic cells in milk
5
TNFα= Tumor necrosis factor- α
a
P>0.05
b
P<0.05
2
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Micro

3

SCC

4

0.48
b
0.57
b
0.45
b
0.43

b

0.40
b
0.50
b
0.38
b
0.48

b

0.46
b
0.18
b
0.53

0.42
b
0.27

b

b

glands are highly susceptible to new S. uberis IMI (Smith et al., 1985; Todhunter
et al., 1995; Jayarao et al., 1999). The bacterial strain used to cause
experimental S. uberis infection (UT888) induced clinical mastitis in the majority
of challenged mammary glands, as reported previously (Fang et al., 1998a;
Hockett et al., 2000).
The objective of this study was to study the dynamics of leukocytes and
inflammatory cytokines during experimentally-induced S. uberis mastitis in order
to gain a better understanding of the pathogenesis of this disease in lactating
dairy cows. The process of leukocyte recruitment and cytokine production during
mastitis has been studied extensively using gram-negative infection models,
such as mammary gland bacterial challenge with E. coli and Klebsiella
pneumoniae (Rose et al., 1989; Shuster et al., 1996; Shuster et al., 1997; Blum
et al., 2000; Riollet et al., 2000), or endotoxin infusion (Shuster et al., 1993;
Rainard and Paape, 1997; Paape et al., 2002). To our knowledge, this is the first
report of cytokine production during IMI with S. uberis. The present study was
conducted to determine the characteristics of the host response to IMI with S.
uberis, a gram-positive environmental mastitis pathogen, which differs greatly
from E. coli and other gram-negative pathogens in virulence, growth
characteristics and ability to persist in the udder environment.
Data from studies using the E. coli mastitis model, to which most
comparisons have to be made due to the extensive information published on it,
differs considerably from results of the present study. Probably, one of the more
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important differences is the clinical course of infection. In the present study,
clinical signs of mastitis were not detected until 72 to 108 hours following
challenge. With the E. coli experimental infection model, clinical signs were
evident within the first 8-16 hours after challenge, and signs are usually resolved
without any therapeutic intervention within the first week after challenge (Hill et
al., 1978; Shuster et al., 1997).
Bacterial challenge of mammary glands with S. uberis UT888 provoked
clinical mastitis in 16 of 20 challenged mammary glands. Appearance of clinical
signs coincided with detection of large numbers of bacteria (>5,000 CFU/ml) in
challenged mammary glands. Large numbers of bacteria (>5,000 CFU/ml) in milk
were not detected until 84 hours after challenge, suggesting a lag phase in the
ability of S. uberis to adapt and grow in the mammary gland. One possible
explanation for this lag phase is that S. uberis may require a period of adaptation
to the mammary environment, after which it is able to colonize the mammary
gland. Streptococcus uberis is highly auxotrophic and depends on acquisition of
several amino acids and other nutrients to grow successfully (Leigh, 1994b). Milk
from lactating mammary glands is deficient in free or peptide associated amino
acids. In order to infect the mammary gland S. uberis must possess a
mechanism to acquire amino acids for growth. Leigh (1993) demonstrated that S.
uberis was capable of converting plasminogen to plasmin which in turn degraded
casein and generated by-products needed for optimal bacterial growth.
Furthermore, a plasminogen activator, designated PauA, was isolated from S.
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uberis (Leigh, 1994b). Other studies of experimental S. uberis IMI with a different
strain (S. uberis O140J;Hill, 1988; Smits et al., 1998) suggest a similar lag phase
although of shorter duration, probably due to a higher pathogenicity of the strain
used. Nevertheless, our findings and data from other studies (Hill, 1988; Smits et
al., 1998) suggest that upon intramammary inoculation, S. uberis requires some
time to adjust to the mammary gland environment. Bacteria may then produce
plasminogen activator which would activate plasmin and therefore allow better
nutrient availability for optimal growth. This “adaptation period” apparently
needed by S. uberis is in marked contrast with the remarkable ability of E. coli to
grow in the mammary gland environment even 2 hours after inoculation into the
mammary gland (Shuster et al., 1995; Shuster et al., 1996; Riollet et al., 2000).
In contrast to the delay in increases of bacterial numbers, the number of
somatic cells in milk increased significantly as early as 18 hours after challenge
with S. uberis, and were 100-fold greater than prechallenge values at 48 hours
after challenge, when S. uberis was still detected in very low numbers (<100
CFU/ml). This would suggest inability to control growth of S. uberis in the
mammary gland in spite of massive leukocyte infiltration from the bloodstream.
Interestingly, this contrasts with findings using the E. coli experimental infection
model, where bacterial numbers increase tremendously during the first hours of
infection without apparent recognition by the host and therefore minimal
leukocyte recruitment into the mammary gland (Shuster et al., 1995; Shuster et
al., 1996; Riollet et al., 2000).
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Based on our findings, it seems that host recognition of S. uberis during
the initial stages of infection is not impaired, as demonstrated by the significant
increase in the number of somatic cells in milk from challenged mammary glands
within the first 24 hours after challenge. This is in agreement with other studies
(Thomas et al., 1994; Smits et al., 1998). Phagocytosis by PMN is a crucial
process in the elimination of E. coli (Hill et al., 1978) and S. aureus (Schalm et
al., 1976) from the bovine mammary gland. The inability of PMN to phagocytose
and kill certain strains of S. uberis has been reported in vitro (Leigh and Field,
1991; Leigh and Field, 1994) and in vivo (Thomas et al., 1994). Resistance of S.
uberis to the bactericidal action of PMN in vitro was induced by growth of
bacteria in media containing casein-derived amino acids and peptides (Leigh and
Field, 1991) which may mimic the state within the mammary gland during
infection. In a study by Thomas et. al. (1994) where pathologic findings of S.
uberis infection were evaluated in vivo, a large neutrophil response was
observed, and considered rather disproportionate to the number of bacteria
present in milk. In the same study, very few bacteria were detected inside PMN,
raising questions about the role of PMN in elimination of S. uberis from the
infected mammary gland (Thomas et al., 1994). Results from our experiment also
suggest that massive recruitment of PMN was not sufficient to eliminate S. uberis
from infected mammary glands.
A significant decrease in blood leukocyte counts was observed 72 hours
after challenge with S. uberis. This decrease was not coincident with an increase
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in the number of somatic cells, which occurred earlier, but it resembles findings
by Smits et. al. (1998) where a significant decrease in blood leukocyte counts
was observed 48 and 72 hours after S. uberis challenge. However, the study by
Smits et. al. (1998) was conducted with a more virulent strain of S. uberis (strain
O140J), which generally causes clinical disease between 24 and 60 hours after
challenge (Hill, 1988; Thomas et al., 1994; Smits et al., 1998), earlier than
observed in our experiment with S. uberis UT888. During experimental E. coli or
endotoxin induced mastitis, where the inflammatory episode is more marked and
sudden, the decrease in circulating blood leukocytes was simultaneous to the
increase in the number of somatic cells in the udder (van Werven et al., 1999;
Paape et al., 2002).
The importance of cytokines in neutrophil recruitment is well established.
However, cytokine production during S. uberis mastitis has not been
documented.

In the present study, cytokine production was assessed in S.

uberis challenged mammary glands as well as control unchallenged mammary
glands. Interestingly, TNF-α, IL-1β and IL-8 were not detected in significant
amounts in milk from infected mammary glands until 66 hours after challenge. All
three cytokines measured were significantly elevated by 66 hours, when clinical
signs still were not observed. However, at 66 hours after challenge, numbers of
somatic cells had almost reached the maximum amount observed in this study
(6.64 log10 SCC/ml). It has been demonstrated that, after migration into an
inflammatory site, leukocytes begin to synthesize and release their own particular
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set of cytokines within target tissue (Lloyd and Oppenheim, 1992). The massive
influx of neutrophils into the mammary gland observed in our study may have
been responsible for the simultaneous increase in cytokine concentrations at this
time, since neutrophils, especially in large quantities, can be an important source
of IL-1, TNF-α and IL-8 (Lloyd and Oppenheim, 1992; Xing et al., 1993).
Peak TNF-α production was observed preceding peak clinical signs of
mastitis. The TNF-α concentrations tended to increase gradually towards a peak
at 120 hours. Great variability was observed between cows, but all challenged
infected mammary glands showed detectable amounts of TNF-α. This contrasts
with findings reported by Shuster et. al. (1997), where TNF-α bioactivity after
challenge with E. coli was detected only in mammary glands with severe
infection. Similarly, in a previous study by Shuster et al. (1993) where mammary
glands were challenged with 10 µg of endotoxin, TNF-α activity was not detected
in any of the challenged mammary glands. In our study, however, even
mammary glands with moderate infections showed a significant increase in TNFα concentration.
Low concentrations of TNF-α were detected as early as 12 hours after
challenge in some mammary glands. The relative importance of the very low
amounts of TNF-α found in some mammary glands in the early stages of
infection is questionable, given the fact that concentrations were close to the
lower detection limit of the assay (80 pg/ml) and that low levels of TNF-α were
also found in some control unchallenged mammary glands. Nevertheless, TNF-α
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biological activity has been observed at 10 pg/ml (Riollet et al., 2000), therefore
activity of TNF-α in those samples or even in samples where no TNF-α was
detected cannot be excluded. The TNF-α concentrations observed in our study
were 30-fold smaller than those reported in E. coli or endotoxin experimental
infections (Rainard and Paape, 1997; Riollet et al., 2000; Paape et al., 2002). Of
note, comparisons between our study and others (Rainard and Paape, 1997;
Riollet et al., 2000; Paape et al., 2002) may be of relative value due to
differences in sample processing and time of analysis. Nevertheless, the findings
that TNF-α concentrations were much lower than reported for E. coli
experimental infections is not surprising, since other studies using different
infection models with other infectious agents have shown little or no detection of
TNF-α in spite of the presence of acute inflammatory signs (Baarsch et al., 1995;
Tissi et al., 1999).
Concentrations of IL-1β were also significantly elevated 66 hours after
challenge with S. uberis. The pattern of increase of IL-1β was not gradual; this
may be explained by differences in peak concentrations for individual mammary
glands, which did not occur at the same time. Nevertheless, IL-1β remained
significantly elevated until 120 hours. Interestingly, the 4 challenged mammary
glands that did not become infected exhibited an increase in IL-1β concentrations
in a pattern that was similar to that of infected mammary glands. This observation
was surprising, considering that IL-1β is one of the acute phase cytokines
responsible for clinical signs of inflammation (Baumann and Gauldie, 1994) , and
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the 4 uninfected mammary glands did not show any clinical signs of
inflammation. Interleukin-1β is one of the main cytokines found during
experimental E. coli mastitis, with peak concentrations coinciding with the
establishment of clinical signs (Shuster et al., 1997; Riollet et al., 2000). Since IL1β

concentrations

in

control unchallenged mammary glands remained

significantly lower than challenged mammary glands, findings of increased IL-1β
concentrations and numbers of somatic cells in the 4 challenged uninfected
mammary glands indicate that a mild inflammatory response did develop, but this
response might have been enough to control the infection without any detectable
clinical signs.
Similar to TNF-α, small amounts of IL-1β were detected in some
prechallenge and control unchallenged samples. Other investigators have
reported low concentrations of TNF-α and IL-1β in secretions of noninflamed
mammary glands or unstimulated mammary epithelial cultures (Sordillo et al.,
1990; Basolo et al., 1993; Shuster et al., 1997). The physiological significance of
basal levels of these mediators is unknown. Shuster et. al. (1997) suggested that
these mediators may contribute to the small influx of leukocytes that occurs even
in uninfected mammary glands.
Interleukin-8 was detected only in challenged mammary glands that
became infected. The IL-8 increase was observed simultaneously to increases in
TNF-α and IL-1β concentrations. Others have shown that TNF-α and IL-1β
stimulate IL-8 secretion (Larsen et al., 1989; Boudjellab et al., 2000). Riollet et.
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al. (2000) reported that high levels of IL-8 were found not only in mammary
secretions but also in mammary cells from an E. coli infected cow, suggesting
that the real quantities of IL-8 present in mammary secretions from infected
glands may be underestimated. Since IL-8 has the ability to link itself to cell
membrane receptors or to be rapidly internalized by cells (Marie et al., 1997), it is
possible that larger amounts of IL-8 may have been produced, but not detected
in the mammary secretion analysis.
Cytokine involvement in leukocyte migration to an inflammatory site is well
documented (Cybulsky et al., 1988; Baggiolini et al., 1989; Persson et al., 1993;
Shuster et al., 1997). Cytokines mediate leukocyte recruitment to inflammatory
sites by their chemotactic ability and by activation of adhesion molecules on
circulating leukocytes and endothelial cells in the adjacent vasculature (Shuster
et al., 1993; Shuster et al., 1997). Shuster et. al. (1997) reported that production
of inflammatory mediators during experimental E. coli mastitis was coincident
with a dramatic increase in the number of somatic cells, suggesting that upon
bacterial recognition by the host, inflammatory mediators were produced and
leukocytes recruited into the infected mammary gland. In our study, however,
leukocyte recruitment into challenged mammary glands occurred earlier than
significant local production of TNF-α, IL-1β or IL-8. These three cytokines, on the
other hand, are not the only soluble factors involved in the inflammatory
response. Many other mediators such as histamine, serotonin, complement
fragments, prostaglandins and leukotrienes may be responsible for increased
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vascular permeability and leukocyte migration during the early phase of mastitis.
Giri et. al. (1984) reported that prostaglandin concentrations in endotoxin-infused
mammary glands preceded increased leukocyte counts. Additionally, Rose et. al.
(1989) suggested that leukotriene B4 (LTB4) may be the principal neutrophil
chemotactic factor in mastitis, although increased numbers of somatic cells
preceded increases in milk LTB4. Furthermore, Shuster et. al. (1993) reported
that swelling and increases in mammary gland permeability after endotoxin
infusion preceded detection of TNF-α, IL-1β or IL-6, suggesting that these clinical
changes were mediated by other inflammatory mediators. No information exists
about the role of other inflammatory mediators in S. uberis mastitis.
Rose et al. (1989) suggested that higher concentrations of inflammatory
mediators in the tissue of a mastitic mammary gland may precede any increases
observed in milk. The exact site of inflammatory mediator production in the
infected mammary gland is unknown. Macrophages produce many inflammatory
mediators upon bacterial stimulation, but epithelial cells can also generate a
variety of inflammatory mediators upon interaction with bacteria (Agace et al.,
1993; Eckmann et al., 1993). A study showed that release of inflammatory
cytokines by epithelial cells was directed toward the basolateral surface, the
direction from which host defenses would be recruited (Eckmann et al., 1993).
Specifically, mammary epithelial cells have been shown to produce IL-1β and IL8 in vitro (Boudjellab et al., 2000). Streptococcus uberis has been shown to
adhere to and invade mammary epithelial cells in vitro (Matthews et al., 1994a;
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Almeida et al., 1996). Therefore, as suggested by Shuster et. al. (1997), it is
possible that cytokines were produced initially by epithelial cells upon contact
with bacteria and that their concentrations may have been greater on the
basolateral surface. As a consequence of this, their biological effects may have
been induced in the interstitium. In this case, cytokine concentration in milk may
have not been an accurate reflection of cytokine production and potential
biological activity, and might explain the apparent delay observed in this study
between cytokine detection in mammary secretions and leukocyte migration into
challenged mammary glands.
The role of adhesion molecules CD11b/CD18 and CD62 was also
evaluated during S. uberis experimental infection. For CD11b, expression was
slightly upregulated at 84, 90 and 114 hours after challenge. The increase in MFI
was rather small, but differences of similar proportion have been reported during
experimental S. uberis mastitis with strain O140J (Smits et al., 1998). The MFI
for CD18 was upregulated 20% at 48 hours after challenge, similar to that
reported by Smits et. al. (1998) during experimental S. uberis mastitis. In our
study, however, increased expression of CD11b and CD18 was not coincident
with an increase in number of somatic cells, which occurred earlier. Interestingly,
Smits et. al. (1998) also reported that diapedesis of PMN from cows challenged
with S. uberis was dramatically diminished, in spite of upregulation of CD11b and
CD18. It is possible that other adhesion receptors may be involved in PMN
migration into the mammary gland. The MFI for CD18 decreased dramatically 96
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hours after challenge, and remained below prechallenge values. Since this is the
period of time when cows were showing clinical signs, it is possible that
endogenous

release

of

cortisol

upon

onset

of

clinical signs

caused

downregulation of CD18 expression, as suggested by others (Burton and Kehrli,
1995; Smits et al., 1998). Using the same mastitis model described in the present
study, Hockett et. al. (2000; 2002a; 2002b) reported a significant increase in
serum cortisol levels 96 hours after challenge with S. uberis UT888 and serum
cortisol remained significantly elevated at 168 hours after challenge (Hockett et
al., 2000; Hockett et al., 2002a; Hockett et al., 2002b). This time period between
96 and 168 hours after bacterial challenge is coincident with the marked
downregulation of CD18 observed in our experiment. Therefore, it is possible that
increased serum cortisol may have caused downregulation of CD18. No
significant variation was detected in CD62 expression, except for an
unexplainable increase in MFI at 108 hours after challenge.
In conclusion, this study provides insight into the inflammatory response
during experimental S. uberis mastitis. Leukocyte recruitment into mammary
glands was prompt and significant, though appeared to be ineffective in
controlling the onset of infection. Intramammary infection with S. uberis elicited
local production of cytokines, and peak concentrations of TNF-α, IL-1β and IL-8
were reached once clinical signs had been established. Expression of adhesion
molecule CD11b/CD18 was upregulated, but a significant increase in the number
of somatic cells was observed before upregulation of CD11b/CD18. These
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findings suggest that other factors may be involved in initial leukocyte recruitment
into mammary glands after S. uberis infection, and that TNF-α, IL-1β and IL-8
may be responsible, at least in part, for the observed clinical signs. Future
studies focused on the early events that take place after bacterial challenge may
help to elucidate the pathogenesis of S. uberis mastitis and the development of
more effective control measures for S. uberis mastitis in dairy cows.
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Appendix 1. Enumeration of Streptococcus uberis (colony forming units/ml) in milk from mammary glands
experimentally infected.
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Holstein cows were challenged with 10,500 CFU/ml of S. uberis UT888.
Jersey cows were challenged with 6,650 CFU/ml of S. uberis UT888.
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LR= Left rear mammary gland; LF= Left front mammary gland; RF= Right front mammary gland; RR= Right rear mammary gland.
2

Appendix 2. Timeline of events during experimentally-induced Streptococcus uberis mastitis.
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1
ATB=antibiotic therapy. Three mammary glands received antibiotic therapy at 120 hours, 8 mammary glands received antibiotic therapy at 144 hours and 4 mammary glands
received antibiotic therapy at 168 hours after intramammary inoculation with S. uberis.
2
TNFα= tumor necrosis factor-alpha
3
IL-1β= interleukin-1 beta
4
IL-8= interleukin-8
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